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 The whole food chain project 
This master thesis is part of a 3-year project funded by the Norwegian research council 
(199626). The project objective is to investigate the effect of replacing high portions both fish 
meal and fish oil with plant protein and vegetable oils on the “whole food chain” of Atlantic 
salmon farming; from fish feed to fish health and finally health effects on consumer eating 
salmon fed novel diets (see figure below for a schematic overview over the project). The 
experimental feeds will be evaluated for their safety and the health of the fish and the health 
effect of eating salmon fed novel feeds will be studied, focusing on obesity and 
cardiovascular diseases. By investigating effects of the plant-based feed on the Atlantic 
salmon and the consumers, the aim is to increase the knowledge about the effect in the whole 
food chainto consumer health.  
 
 
FIGURE 1: OUTLINE OF THE WHOLE FOOD CHAIN PROJECT, BFR: BROMINATED FLAME RETARDANTS. 
 
 Abstract 
To ensure responsible use of the valuable marine ingredients a major effort is being invested 
in understanding effects of replacing fish meal and fish oil partially or completely with plant 
proteins and vegetable oils in aquaculture diets. Decreased dietary n-3/n-6 ratio and 
cholesterol levels and the introduction of vegetable oil derived phytosterols may affect 
Atlantic salmon health as well as nutritional product quality.  
Atlantic salmon plasma cholesterol is naturally very high being more than twice the upper 
range for healthy humans (11 mM in salmon vs 5 mM for healthy humans). Increased plasma 
and LDL cholesterol is a known risk factor for the development of cardiovascular disease in 
humans and phytosterols are known to lower plasma cholesterol. In Atlantic salmon, 
however, the role of dietary phytosterols as cholesterol lowering agents is still unexplored. 
The aim of the study was to investigate if the cholesterol metabolism and plasma cholesterol 
levels were altered in seawater phase Atlantic salmon when fed diets with either fish oil (FO) 
or vegetable oil (VO) based feeds for 6 months. The fish were fed diets with a high and 
constant inclusion of plant proteins, and either fish oil (FO) or 80 % of the FO replaced by 
olive oil (OO), rapeseed oil (RO) or soybean oil (SO). These oils were selected for their 
different levels of phytosterols and n-3/n-6 ratios to make it possible to determine whether it 
was the sterol composition of the feeds or the fatty acid composition being the main factor 
affecting fish cholesterol metabolism.  
Neither plasma nor lipoprotein cholesterol differed at any sampling point between Atlantic 
salmon fed the different experimental diets, indicating that cholesterol levels is metabolically 
regulated also in Atlantic salmon. Phytosterols tended to accumulate in liver, especially in the 
fish fed RO, which was the diet with the highest content of phytosterols. An increased mRNA 
expression of genes encoding for proteins involved in cholesterol synthesis (ACAT2, DHCR7 
and SREBP2) was observed in VO fed fish. Higher triacylglycerol levels in the liver, as well 
as a slightly elevated VLDL cholesterol and protein was seen in the RO fed fish compared to 
the other dietary groups. The changes observed in the RO fed salmon are thought to be caused 
by lower absorption of dietary cholesterol in this dietary group, caused by an influence of 
phytosterols on the intestinal sterol-absorber NPC1L1.The results from this study indicate that 
as long as Atlantic salmon is fed vegetable ingredient based diets low in cholesterol, 
cholesterol synthesis is up regulated, and dietary phytosterols does not affect the plasma nor 
lipoprotein cholesterol levels further. However, a high phytosterol-low cholesterol diet, as 
provided by the RO feed, does have a significant effect on the lipid and sterol metabolism on 
these fish, possibly due to a cholesterol deficit. 
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1. Introduction 
1.1 General introduction  
Replacement of marine raw material in aquaculture feed with plant ingredients 
The aquaculture industry in the world is today the fastest growing food sector, growing by an 
average of 6.6% each year (1970-2008). Worldwide, fish from aquaculture represents 50% of 
the human fish consumption, and it has been viewed as an alternative to take the pressure of 
the decreasing fish stocks in our oceans. Already in 2006 the export value of farmed fish in 
Norway overgrew the value of wild catch fish, and the national production has grown by 10% 
each year (FAO, 2011). But the pressure on the wild caught fish is not off; about 87% of all 
the fish oil (FO) produced globally is used by the aquaculture industry as a source of lipids, 
with the farming of salmonid species  accounting for the consumption of as much as 66.4% of 
the total amount of FO used in aquaculture in 2003 (Tacon et al., 2006). Most of the stocks of 
the top ten fished species are already fully exploited or overexploited. Because of a growing 
concern for the marine resources and organic contaminants in the raw material as well as 
varying availability of marine prime material, a big effort is being put into replacing FO and 
fish meal in the fish feed partially or completely with alternative material (FAO, 2010; Miller 
et al., 2008). With an increasing production and competitive prices of vegetable oils (VO), 
these are viewed as a good as substitutes for FO. Some of the uncertainties concerning this 
change in the fish‟s diet have been whether or not the fillet of the farmed fish eating more 
plant derived food will keep its valued health benefits and if the general health and wellbeing 
of the fish will change in any way (Turchini et al., 2009). 
When replacing the marine raw materials in aquaculture feeds with plant raw materials there 
are several dietary factors that are changed. Some of the most obvious ones are the fatty acid 
and indispensable amino acid composition, as well as the possible presence of environmental 
contaminants new to the aquaculture industry and plant metabolites as phytosterols. Other 
components that may be introduced into the aquaculture feed with the plant material are 
antinutritional factors and complex carbohydrates (Francis et al., 2001; Vielma et al., 2003). It 
has been shown that 90% of the fish meal can be replaced by plant protein mixture with 
balanced amino acid composition without the fish showing any signs of decrease in growth 
rate (Espe et al., 2006). Also, replacing the fish oil with a mixture of vegetable oils, but 
keeping the protein source of marine origin has shown good overall performance (Leaver et 
al., 2008; Miller et al., 2008; Nanton et al., 2007; Torstensen et al., 2005). In contrast, when 
both protein and oil fraction was replaced by plant ingredients, lowered growth and increased 
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overall adiposity was reported (Torstensen et al., 2008; 2011). Most studies done on the effect 
of different fatty acids and sterols on the organism is performed with mice or other test 
animals to obtain results related to human health and nutrition. However, an increasing 
amount of studies within the same field are also performed on fish, both of which are more 
thoroughly covered in section 1.3 and 1.4 of the introduction.  The research done on minor 
constituents of plant based diets are few and the attention to this field has been enquired 
(Turchini et al., 2009). It has been shown by microarray studies that VO diets influence the 
cholesterol metabolism in Atlantic salmon (Leaver et al., 2008; Taggart et al., 2008), although 
there is a need to better understand the mechanisms of this effect the VO diet exerts on the 
metabolism. The effect of plant sterols, called phytosterols, on the cholesterol metabolism in 
Atlantic salmon is the main focus in this master thesis. The effect of changes in fatty acid 
composition on cholesterol metabolism has also been investigated.  
1.2 Theoretical background 
Characteristics of sterols 
-General information on sterols and their chemical structure 
The sterols are mainly divided into two groups, the 
animal sterols, zoosterols, and the plant equivalents, 
which are called phytosterols. Cholesterol is the 
main zoosterol and is vital for the human body, 
being part of cell membranes, and acting as substrate 
for the production of bile acid and steroid hormones 
in animals (Schneider, 2008). The biological function 
of phytosterols is similar to that of cholesterol, as 
they help stabilising the phospholipid bilayers of the plant cell membranes, and have also 
been proven the ability to lower levels of harmful cholesterol in human plasma (more details 
in section 1.3). The structure of sterols is composed of a tetracyclic cyclopentana-
phenanthrene structure with trans ring junctions, and a side chain at C-17. The basic sterol 
structure, as seen in figure 1.1, is defined as 5α-cholesten-3β-ol and is the structure of which 
other sterols are defined. The chemical structures of phytosterols are quite similar to 
cholesterol, except that the phytosterols always contain some kind of substitution on the C-24 
position on the side chain (see figure 1.1 and 1.3).  
-Dietary sources of sterols 
Sterols are lipid soluble and are therefore found in the fatty portions of food products.  Some 
FIGURE 1.1: 5Α-CHOLESTEN-3Β-OL BASIC 
STRUCTURE OF WHICH OTHER STEROLS ARE 
DEFINED 
(SOURCE: LIPIDLIBRARY.AOCS.ORG) 
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of the most common sources of cholesterol in the western diet are cheese, egg yolks, beef, 
pork, poultry, and shrimp (U.S. Department of Agriculture, 2010). Phytosterols are found in 
seeds, legumes and unrefined vegetable oils, and are common in cereals (Weihrauch and 
Gardner, 1978). Phytosterols are only synthesized in plants, so the levels in animals come 
solely from food via intestinal absorption. The most common phytosterol sources in the 
western diet are corn, bean and plant oils, and intake can vary from 250 mg per day, as in the 
USA (Connor, 1968), to about the double for a vegetarian (Cerqueira et al., 1979). Bivalves 
are also rich in sterols, which reflects their varied phytoplankton food sources (Copeman and 
Parrish, 2004). 
In spite of ingestion of relatively large quantities of foods with phytosterols, the amount of 
phytosterols absorbed into the human body is low; only about 5% of the phytosterols ingested 
are absorbed, compared to a 40% for cholesterol (Salen et al., 1989). The difference in 
absorption between cholesterol and phytosterols is thought to be due to the crucial step in the 
absorption of sterols, the acyltransferase dependent esterification, is slower for phytosterols 
than for cholesterol. It has been shown that the acylcoenzyme of cholesterol, A:cholesterol 
acyltransferase  (c-ACAT), is at least 60 times greater than that of β-sitosterol (Ling and 
Jones, 2005; Miettinen et al., 1990).   
-Lipid sources relevant for the aquaculture industry 
For a lipid to replace FO in aquaculture feed, it should optimally resemble the composition of 
FO, which is an oil rich in the highly unsaturated n-3 fatty acids (n-3 HUFA), but with the 
main portion of the energy suministred by saturated fatty acids and monounsaturated fatty 
acids (MUFA) (Henderson and Sargent, 1985). The amount of  saturated FAs to be used in 
the feed has to be viewed in context with the temperature of the water for the fish to be fed 
with the diet, as saturated FAs have a lower digestibility than unsaturated FAs in fish and then 
especially in cold-water fish (Francis et al., 2007; Menoyo et al., 2003; Ng et al., 2004; 
Torstensen et al., 2000).  Oils have been used singly or as blends in earlier experiments to 
investigate their suitedness as a replacement for FO (Leaver et al., 2008; Nanton et al., 2007; 
Torstensen et al., 2008) and the effects of replacing FO with different VOs is reviewed in 
section 1.4 of this paper. When selecting oils for a fish diet the need for the essential fatty 
acids, linoleic acid (18:2 n-6, LA) and α-linolenic acid (18:3 n-3, ALA), has to be considered, 
as these cannot be synthesized by vertebrates (Cunnane, 2003; Turchini et al., 2009). ALA 
can be converted into n-3 HUFA by specific desaturates and elongases which have shown to 
increase their activity in Atlantic salmon fed diets where FO has been replaced by VO 
(Stubhaug et al., 2005; Tocher et al., 2003; 2001). Some of the oils that could be used in the 
aquaculture industry are described below, as are their FA and sterol compositions. 
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Rapeseed oil was earlier known for high levels of erucic acid (22:1 n-9) 
and undesirable levels of glucosinolates. The modern rapeseed (also 
called canola) has been selected to not have these “defects” and now it 
is the third largest source of oil for human consumption after soybean 
and palm oil. A typical rapeseed oil contains less total saturated fatty 
acid (SFA) than any other commodity oil (about 7% of total fatty acid 
content, vs. 15% in olive and soybean oil), and is a natural source of 
plant sterols. In addition, rapeseed oil has been observed to have a high 
acceptance in Atlantic salmon and rainbow trout (Oncorhynchus 
mykiss) compared to other VOs (Geurden et al., 2005 ; 2007) 
Olive oil is an important part of the Mediterranean diet and has long 
been accredited to have positive effects on cardiovascular health in 
humans. It is characterized by its high levels of oleic acid, 18:1 n-9 
(almost 80% of total FA), a monounsaturated fatty acid (MUFA). The 
virgin oil also contains tocopheroles (vitamin E) and an appreciable 
amount of squalene (an acyclic C30 hydrocarbon, biological precursor 
of sterols), although many of these health promoting substances get 
denatured or removed during distillation. 
 
Soybean oil is the second most produced oil after palm oil. Its high 
levels of unsaturated fatty acids makes it very unstable and prone to 
oxidation, so it is therefore usual to half the amount of LA by 
hydrogenation to give it a longer shelf life. The dietary shortcoming 
with this oil is its lower than recommended n-3/n-6 ratio.  
Linseed oil is very rich in PUFA, especially the n-3 PUFAs, and is one of the few VOs that 
provide ALA in substantial amounts (~50% of total FA). It is, however, not well accepted by 
Atlantic salmon and rainbow trout compared to other VOs (Geurden et al. 2005; 2007). 
Palm oil has high contents of the saturated FA palmitic acid (16:0) and the monounsaturated 
FA oleic acid. It is naturally rich in carotenes and tocotrienols, but these are often removed 
during the refinement process. This oil has physical properties valued by many industries, as 
it is semi-solid at room temperature and can thus give texture to food and cosmetics (Dubois 
et al., 2007). 
Echium oil stands out for its high levels in stearidonic acid (18:4 n-3), which is one step 
higher than ALA in the elongation and desaturation pathway towards the biosynthesis of n-3 
HUFA. Echium oil has been seen to increase the amount of n-3 HUFA in fish tissues when 
used as lipid source in aquaculture feed for Atlantic cod, Gadus morhua (Bell et al., 2006). 
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Sunflower seed oil contains linoleic and oleic acids as the major FAs, which often make up 
over 90 % of the total FAs in this oil. High-oleic varieties do also exist for this oil, where up 
to 90% of the oil is made up of oleic acid. 
All vegetable oils are different from marine oils in the sense that they do not have carbon-
chains longer than 18-C and have no more than 3 double bonds (table 1.1).  The other main 
difference between plant oils and fish oil is the absence of cholesterol and presence of plant 
sterols, called phytosterols, which are not synthesized in animals. The rapeseed oil is 
characterized as a high-phytosterol oil while the olive and soybean oil are viewed as 
low/intermediate-phytosterol oils (table 1.2). 
All information seen here about vegetable oils, when not otherwise cited, from 
lipidlibrary.org 
TABLE 1.1: OVERVIEW OVER TYPICAL FATTY ACIDS COMPOSITIONS OF SELECTED VEGETABLE OILS (GIVEN AS 
W/W%)  
Fatty acid Olive 
oil 
Rapeseed 
oil 
Soybean oil Linseed Palm oil Echium oil Sunflower 
oil 
Total Saturated 15.3 8.0 15.7 10.0 50.4 11.1 12.8 
18:1 n-9 72.5 60.1 23.9 18.4 39.1 15.4 22.1 
20:1 n-9 0.3 1.4 0.1 - 0.1 0.8 0.2 
22:1 n-9 - 0.4 - - - 0.3 0.1 
Total MUFA 73.8 76.8 24.2 18.5 39.4 17.2 22.4 
18:2 n-6 9.4 21.5 52.1 16.8 10.2 18.8 65.6 
18:3 n-3 0.6 9.9 7.8 55.0 0.3 28.4 0.5 
Total PUFA 10.0 31.5 59.8 71.8 10.5 71.7 66.0 
Total n-6 9.4 21.6 52.1 16.8 10.2 29.8 65.6 
Total n-3 0.6 9.9 7.8 55.0 0.3 41.2 0.5 
Ratio n-3/n-6 0.06 0.46 0.15 3.27 0.03 1.4 0.007 
 
 
TABLE 1.2: TYPICAL STEROL COMPOSITION OF SELECTED VEGETABLE OILS (MG KG-1) 
  Olive oil Rapeseed oil Soybean oil Linseed oil Palm oil 
Campesterol 28 1530 720 1218 358 
Stigmasterol 14 - 720 378 204 
β-sitosterol 1310 3549 1908 1932 1894 
Δ5-avenasterol 29 122 108 546 51 
Δ7-stigmastenol 58 306 108 84 25 
Δ7-avenastenol - - 36 - - 
Brassicasterol - 612 - - - 
Total: 1439 6119 3600 4158 2532 
Source:  (Harwood et al., 1994) 
 
Source: vegetable oils: (Dubois et al., 2007) ; echium oil: (Surette et al., 2004) 
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Fish oil is produced by using the whole fish as a raw material and 
extracting the fat. It is the edible oil with the highest level of n-3 fatty 
acids and provides the health promoting n-3 highly unsaturated fatty 
acids (HUFAs) such as Eicosapentaenoic acid (EPA, 20:5 n-3) and 
Docosahexaenoic acid (DHA, 22:6 n-3). The FA composition of fish 
oil varies depending on the fish species used, the season and where it 
is caught. In table 1.3 FA compositions of oils from various fish 
species is listed; if possible, the values are taken from the period when the fish is at its fattest 
period during the year. There is a great variation through the year and between the species in 
the oil they render, a fact to have in mind when considering different fish oil sources. Fish 
oils do not contain phytosterols other than in trace amounts, and differ in cholesterol contents 
which are typically 7100 mg kg
-1
 for sardine oil and 7660 mg kg
-1
 for herring oil (U.S. 
Department of Agriculture, 2010). 
 
 
TABLE 1.3: OVERVIEW OVER TYPICAL FATTY ACID COMPOSITIONS OF FISH OIL FROM ANCHOVY AND SARDINE, 
AND SALMON DIETS BASED ON 100% FISH OIL FROM CAPELIN AND HERRING (DATA GIVEN AS W/W%) 
Fatty acid Capelin Sardine Herring Anchovy 
Total Saturated 20.8 33.6 25.1 46.6 
18:1 n-9 10.9 4.3 21.2 9.3 
20:1 n-9 12.2 1.4 4.6 1.9 
22:1 n-9 1.9 0.9 0.1 0.6 
22:1 n-11 14.5 NA 9.7 NA 
Total MUFA 51.0 18.2 48.6 18.2 
EPA 9.3 10.3 5.5 11.9 
DHA 7.0 18.1 5.4 12.2 
18:2 n-6 2.1 1.5 5.9 1.1 
18:3 n-3 0.6 - 0.7 - 
Total n-6 2.6 4.6 6.5 1.59 
Total n-3 22.5 33.0 13.1 25.9 
Ratio n-3/n-6 8.6 7.2 2.0 16.3 
Total PUFA 25.7 48.2 26.3 35.2 
Source: capelin: Torstensen et al. 2000; sardine and anchovy: Zlatanos and Laskaridis, 2007;  herring: Hardy et al. 1987 
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FIGURE 1.2: SCHEMATICAL VIEW OF SOME OF THE 
COMPONENTS INVOLVED IN THE INTESTINAL 
ABSORPTION OF STEROLS. SOURCE: AGELLON 2008, 
VOELKER 2008 
Sterol absorption 
The cholesterol absorption in humans 
takes place in the jejunum of the small 
intestine, where both dietary and biliary 
cholesterol is available for absorption. The 
dietary cholesterol is taken up into the 
enterocytes by Niemann-Pick C1-like 
receptors (NPC1L), and its absorbance is 
dependent on an esterification by Acyl-
CoA: cholesterol acyltransferase (c-
ACAT) and the subsequent incorporation 
into chylomicrons by microsomal 
triglyceride transfer protein (MTP). 
Cholesterol that is not esterified will not be 
taken up by the chylomicrons and will be 
transported back into the intestinal lumen 
by ATP-Binding Cassette sub-family G (ABCG) transporters, figure 1.4 (Huff et al., 2006; 
Voelker, 2008). The movement of cholesterol from the intestine into the circulation is 
therefore directly dependent on the efficacy of c-ACAT. The sterol-absorber, NPC1L1, has a 
sterol sensing domain, which several other sterol regulating proteins also have (Altmann et 
al., 2004). 
 
Biosynthesis of sterols 
Mammalian whole-body cholesterol homeostasis is a highly regulated balance of de novo 
synthesis, dietary cholesterol absorption, and biliary clearance and excretion (Altmann et al., 
2004; Liscum, 2008). Cholesterol is synthesized in basically every tissue from Acetyl-CoA 
and its levels are controlled by feedback inhibition of cholesterol synthesis and a feed-
forward regulation of cholesterol metabolism and catabolism (figure 1.2).  
Cholesterol is, as mentioned, synthesized in the tissues from acetyl-CoA which is first 
interconverted to acetoacetyl-CoA by Acetyl-Coenzyme A Acetyltransferase (a-ACAT) and 
then condensed by 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase (HMGS) to form 
HMG-CoA. HMG-CoA reductase (HMGR) catalyzes the reduction of HMG-CoA to 
mevalonate and is a rate-determining enzyme in the cholesterol biosynthesis, regulated by the 
supply of cholesterol. A series of reactions, initiated by mevalonate kinase (MVK), transform 
mevalonate to isopentenyl pyrophosphate and then further to farnesyl-PP by the enzyme 
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farnesyl-PP synthase. The conversion of farnesyl-PP to squalene is initiated by squalene 
synthase, which is another one of the links in the cholesterol biosynthesis controlled by the 
cholesterol levels in the cell. Cyclisation of squalene to form lanosterol, the first sterol in this 
metabolic pathway, is done by squalene epoxidase and oxidosqualene:lanosterol cyclase, the 
latter one being a ligand activator for liver X receptor (LXR – mentioned about this under 
section sterol metabolism). Through a series of oxidations, reductions, and demethylations, 
lanosterol is finally converted to cholesterol by 7-dehydrocholesterol reductase (DHCR7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The biosynthetic route of phytosterols is similar to that of cholesterol in many ways as it is 
the mevalonate pathway in the cytosol that is responsible for the production of sterols also in 
plants.  The difference between animal and plant biosynthesis of sterols lies in the step of 
cyclisation, which proceeds via lanosterol in animals and fungi and via cycloartenol in 
photosynthesizing organisms. This is, interestingly, despite the presence of lanosterol in 
higher plants (Kolesnikova et al., 2006). By a complex series of reactions, including opening 
of the cycloartenol cyclopropane ring, double bond formation and isomerisation, 
demethylation of C-rings, and methylation of the side chain a huge variety of plant sterols are 
produced, see figure 1.3 (Benveniste, 2004). Of the more than 200 reported phytosterols in 
plants the most common is β-sitosterol (90%), although the sterol composition usually differs 
from tissue to tissue (Schmid and Ohlrogge, 2008).  
 
FIGURE 1.3: THE SYNTHESIS OF CHOLESTEROL FROM ACETYL COA AND ITS NEGATIVE 
FEEDBACK LOOP, WHERE OXYSTEROLS FUNCTION AS A SIGNAL TO THE CELL OF 
CHOLESTEROL EXCESS. (LISCUM, 2008) 
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Sterol metabolism 
Excess cholesterol in the tissues is transformed by oxidation into oxysterols, which are 
suppressors of cholesterol synthesis and also signals of cholesterol excess in a cell (Olkkonen, 
2004). These cholesterol metabolites have the ability to diffuse through cell membranes, 
which removes the need for receptors for the oxysterols to regulate the cholesterol 
metabolism through negative feedback (Liscum, 2008). The oxysterols activate transcription 
of many genes important in the metabolism of cholesterol metabolism by binding to the Liver 
X-receptors (LXR), which belong to the nuclear receptor superfamily of ligand-activated
 
transcription factors (Janowski et al., 1996; 1999). Activation of LXRs increase the 
expression of CYP7A1 and SREBP1c, which are key genes in the cholesterol and lipid 
metabolism and control the cholesterol catabolism and the de novo synthesis of fatty acids, 
respectively (Lehmann et al., 1997; Peet et al., 1998; Repa et al., 2002). Two isoforms of 
LXR are known in humans, LXR-α and LXR-β, where LXR-β is found in metabolically 
active tissues, as liver and small intestine, whilst LXR-α is found more ubiquitiously (Fan et 
al., 2008). Only one isoform of LXR is known for Atlantic salmon (Cruz-Garcia et al., 2009), 
LXRs are nuclear receptors viewed as the main controllers of the sterol metabolism, 
controlling practically all the aspects of the sterol cycle in the organism by acting on genes 
involved in the cholesterol efflux as ABCG5/8, CYP7A1, and NPC1L1 and with this 
protecting the cell from cholesterol overload (Zhao and Dahlman-Wright, 2010). 
Sterol regulatory element binding protein (SREBP) is a nuclear receptor and the main 
regulator of cholesterol synthesis and uptake (Espenshade and Hughes, 2007; Goldstein et al., 
2006). There are three known isoforms of SREBP in humans; SREBP-1a, SREBP-1c and 
FIGURE 1.4: CHEMICAL STRUCTURES OF CHOLESTEROL AND SOME OF THE MOST COMMON 
PHYTOSTEROLS. SOURCE: (Kidambi and Patel, 2008) 
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SREBP-2. SREBP2 is the isoform that most actively regulates genes involved in cholesterol 
homeostasis, like LDLR and sterol biosynthetic enzymes (Horton et al., 1998 ; 2002). Until 
recently, only one isoform of SREBP, similar to SREBP2 was known in Atlantic salmon. 
However, a recent publication described two isoforms, similar to SREBP1 and SREBP2 
(Minghetti et al., 2011). When the cholesterol levels in a cell are high, SREBP is bound by 
SREBP-cleavage activating protein (Scap) and attached to the endoplasmic reticulum by the 
insulin-induced gene, Insig. When cholesterol levels are low, SREBP is split from Insig and 
released from the ER (Gong et al., 2006). The SREBP/Scap complex is transported to the 
Golgi complex by COPII-budded vesicles on the ER, made soluble by a cleavage by a 
protease and then it enters the cell nucleus (Hertzel et al., 2008; Sakai et al., 1998). In the cell 
nucleus it upregulates the expression of genes involved in the synthesis of cholesterol and 
fatty acids (Horton et al., 2002). HMGR is one of the genes which is strongly regulated by 
SREBP2 in mammals, thus making sure that the supply of mevalonate for the production of 
cholesterol is sufficient, see figure 1.2 (Horton et al., 1998). In Atlantic salmon it is suggested 
that other mechanisms than transcriptional control may be important for HMGR regulation 
(Minghetti et al., 2011). In addition to be controlled by SREBP2, HMGR activity is also 
regulated by products of the sterol and isoprenoid pathways which accelerate its degradation 
(Ravid et al., 2000; Roitelman and Simoni, 1992). In contrast to in humans, it does not seem 
as HMGR is as regulated by these pathways in Atlantic salmon (Leaver et al., 2008). 
Sterol excretion 
The excretion of sterols is regulated by the expression of LXR, which affects the expression 
of CYP7A1 and ABCG5/8, both involved in the excretion of sterols (Agellon, 2008; Huff et 
al., 2006). LXR is, as mentioned, activated by oxysterols and LXR agonists are used to 
prevent accumulation of cholesterol and development of atherosclerosis in humans (Joseph et 
al., 2002).  The body can via the gallbladder get rid of excess cholesterol in the form of bile 
acids. Two main pathways are known for the production of gall salt from cholesterol; the 
classical and the alternative (figure 1.5).  The classical one functions only in the liver and 
starts with an α-hydroxylation on C-7 of the cholesterol steroid nucleus, catalyzed by 
cholesterol 7α-hydroxylase, also called cytochrome P450 7A1 (CYP7A1), which is the 
limiting step for this pathway. The classical pathway is considered as the main mechanism for 
production of bile acids by the liver and bile acid output by the liver is correlated with the 
activity of an increased expression of CYP7A1 (Agellon, 2008). The alternative pathway, 
where oxysterols are transformed into bile acids in other tissues than liver, is similar to the 
one of the classical pathway, although two types of enzymes are needed for the complete 
transformation, CYP7B1 and CYP39A1 (LI-Hakwins et al., 2000). 
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FIGURE 1.5: THE TWO MAIN PATHWAYS FOR THE PRODUCTION OF BILE ACIDS FROM CHOLESTEROL: THE 
CLASSICAL AND THE ALTERNATIVE. SOURCE: (Agellon, 2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endogenous transportation of sterols  
When the triacylglycerides (TAGs), fatty 
acids (FAs) and other lipidsoluble 
components are absorbed in the intestine or 
synthesized in the body, they are, because of 
their hydrophobic nature, transported in 
lipoproteins. Lipoproteins are biochemical 
assemblies that contain TAG and cholesterol 
esters in their centre covered by a 
phospholipid layer with free cholesterol 
embedded in it (figure 1.6). The lipoproteins 
are covered by apolipoproteins which 
contribute to the assembly of the lipoprotein, they also provide structural integrity to the 
same, serve as co-activators of enzymes, and act as receptor ligands for cellular uptake (Jonas 
and Phillips, 2008).  
There are several classes of lipoproteins, which are all associated with different types of 
apolipoproteins and categorized according to their density (table 1.4): chylomicrons, high-
density lipoproteins (HDL), intermediate-density lipoprotein (IDL), low-density lipoprotein 
(LDL) and very low-density lipoproteins (VLDL) (figure 1.7). In the intestine the apoB48 
helps packaging ingested TAG and cholesterol into the chylomicron, the same apolipoprotein 
also provides structural support. The apoE in the chylomicron is the ligand for the hepatic 
FIGURE 1.6: LIPOPROTEIN STRUCTURE, SOURCE: 
TOOSOGIE-LIPID-DIAGNOSTICS.BLOGSPOT.COM 
17 
 
Chylomicron, 100-
1000nm
HDL, 5-
15nm
LDL, 18-
28nm
uptake of this structure. The apoCII and CIII, also on the chylomicron, are thought to have an 
effect on the regulation of triglyceride metabolism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 1.4: THE LIPOPROTEINS, THEIR APOLIPOPROTEINS AND MAIN MECHANISMS OF LIPID DELIVERY. TG: 
TRIACYLGLYCEROL, CE: CHOLESTEROL ESTER.  SOURCE: (GARRETT AND GRISHAM, 1999) 
Lipoproteins Major core 
lipids 
Apolipoproteins Mechanisms of lipid delivery 
 
Chylomicron 
 
Dietary TG 
 
A1, A2, A4, B48 
 
Hydrolisis by lipoprotein lipase 
Chylomicron 
remnant 
Dietary CE B48, E Receptor mediated endocytosis by liver 
VLDL Endogenous TG B100, C, E Hydrolisis by lipoprotein lipase 
IDL Endogenous CE B100, E Receptor mediated endocytosis 
by liver and conversion to LDL 
LDL Endogenous CE B100 Receptor mediated endocytosis 
by liver and other tissues 
HDL Endogenous CE A1, A2 Transfer of cholesterol esters 
to liver 
After some TAG is released to peripheral tissue through lipolysis, the chylomicron turns into 
what we call a chylomicron remnant. The chylomicron remnant is taken up by the liver by 
LDL-R or LDL receptor-related protein (Schneider, 2008). VLDL is synthesized in the liver 
and contains apoB100, which gives structural support and serves as a ligand for cellular re-
uptake, apo E, CII and CIII. VLDL is released into circulation, containing endogenously 
produced TAG and cholesteryl esters. Lipolysis in the circulation of VLDL results in LDL 
and IDL, LDL has apoB100 as its only apolipoprotein. The LDL particles are cleared from 
plasma by LDL-receptors (LDL-R), which are present in all tissues. The densest of the 
lipoproteins, HDL, is the lipoprotein mainly involved in reverse cholesterol transport, e.g. 
transport of cholesterol from the periphery to the liver, and contains apoAI as its main 
apolipoprotein. ApoAI is excreted mainly from the liver in a lipid-poor form and accumulates 
VLDL, 25-50nm
FIGURE 1.7: CHEMICAL COMPOSITION AND SIZE OF LIPOPROTEINS. PURPLE: TRIGLYCERIDES; BLUE: PROTEIN; 
RED: CHOLESTEROL; GREEN: PHOSPHOLIPIDS. SOURCE: (GARRETT AND GRISHAM, 1999) 
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cholesterol and phospholipids to form HDL. HDL also serves as a vessel for the exchangeable 
apolipoproteins (AII, CII, CIII and E) (Fielding and Fielding, 2008). In figure 1.8 the flow of 
sterols by lipoproteins is shown schematically. 
 
 
 
 
Lipoproteins and cardiovascular diseases 
In today‟s medicine the ratio of HDL-cholesterol/LDL-cholesterol is given special 
importance, as LDL-cholesterol is observed to be a factor connected to increasing risks of 
developing CVDs (Willett and Sacks, 1991) and higher levels of HDL-C is commonly 
associated with a good cardiovascular health. The main theory is that LDL-C contributes 
towards atherogenesis by accumulation of LDL-C on the arterial wall, whilst HDL-C has the 
opposite effect and brings cholesterol from the arterial walls to the liver and the steroid 
organs (Castelli et al., 1992; Gotto, 2001). The HDL-C also has positive effects on other 
aspects of the cardiovascular health as it helps inhibit oxidation, inflammation, coagulation 
and platelet aggregation and it activates the endothelium (Mineo et al., 2006; Navab et al., 
2005). The American Heart Association states that a level of total cholesterol level of 5mmol 
L
-1
 or a LDL-C under 3 mmol L
-1
 is viewed as an optimal level, protecting you from 
atherosclerosis. Fish, however, has a much higher normal level of total cholesterol,  often 
higher than 10 mmol L
-1
 (Sandnes et al., 1988), with the main proportion of cholesterol as 
HDL cholesterol (Farrell and Munt, 1983).  
FIGURE 1.8: SCHEMATIC OVERVIEW OF 
TRANSPORTATION OF CHOLESTEROL IN 
THE CIRCULATION. THE CHYLOMICRON 
CONTAINS EXOGENOUS CHOLESTEROL 
TAKEN UP IN THE INTESTINE. THROUGH 
LIPASE ACTIVITY IT BECOMES SLIGHTLY 
DENSER AND IS CLASSIFIED AS A 
CHYLOMICRON REMNANT, WHICH IS 
TAKEN UP IN THE LIVER . FORWARD 
CHOLESTEROL TRANSPORT IS 
PERFORMED BY VLDL, PRODUCED IN THE 
LIVER, WHICH DELIVERS CHOLESTEROL 
TO THE PERIPHERAL TISSUES . THROUGH 
LIPOLYSIS IN THE CIRUCLATION, VLDL 
CAN DEVELOP INTO HEAVIER 
COMPONENTS, CALLED LDL AND IDL, 
WHICH ARE TAKEN UP IN THE LIVER BY 
LDL-R . REVERSE CHOLESTEROL 
TRANSPORT IS EXECUTED BY HDL, WHICH 
TRANSPORTS CHOLESTEROL FROM THE 
PERIPHERAL TISSUES TO THE LIVER. 
FIGURE BASED ON INFORMATION FROM 
(Fielding and Fielding, 2008). 
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Dietary factors have been shown to influence the plasma and lipoprotein cholesterol levels in 
humans. Some of the factors shown to increase the LDL-C levels are saturated fatty acids 
(palmitic acid being the SFA increasing LDL-C the most), cholesterol, and excess caloric 
intake leading to obesity (Grundy and Denke, 1990). Phytosterols have shown to be LDL-C 
lowering (see section 1.3). 
In spite of the common use of HDL-C levels to assess risk of developing CVDs, there are still 
doubts as to how the CVD-preventing mechanisms of HDL work.  The relationship between 
HDL-C and CVDs is strong but not absolute, as many other factors, genetic and 
environmental, decide whether or not someone will suffer from CVDs (Chirovsky et al., 
2009). The effect of the diet on the CV health is also not clear, and the interindividual 
variability in effect of dietary treatments has been reported by many researchers to be large 
(Ordovas, 2006). Atlantic salmon have high levels of plasma cholesterol compared to humans 
(Jukema et al., 1995; Sandnes et al., 1988) and they also have an important predisposition of 
suffering from CVDs when they approach their mature age (Seierstad et al., 2008). However, 
what levels of LDL- and HDL-cholesterol that may provoke an increased risk of CVDs in 
Atlantic salmon, and if such an association exists for this species, has not yet been 
determined. 
1.3 Effects of phytosterols on humans 
Effects of phytosterols on plasma cholesterol  
As the studies on the effects of phytosterols on fish are scarce we must rely on some of the 
results from studies meant to investigate the effect of phytosterols on humans, which are 
much more abundant. In mammals, the phytosterols are not absorbed as efficiently in the 
intestine as cholesterol and are also excreted more rapidly from the liver via bile. This leads 
to mammals usually having low levels of phytosterols in their tissues (Ling and Jones, 2005). 
Many studies have now shown that dietary phytosterols reduce total plasma cholesterol and 
LDL cholesterol levels in animals, an attribute it was given already in the early 1950´s 
(Pollak, 1953). Both phytosterols and their saturated form, phytostanols, have been proven to 
reduce the uptake of cholesterol and bile acids from the intestine (Berger et al., 2004; Grundy 
and Mok, 1977; Lichtenstein, 2002; Moreau et al., 2002; Normén et al., 2000).  
The absorbance and the plasma-cholesterol lowering effect of phytosterols is affected by the 
food in which they are incorporated; the efficacy of bread and cereals as plant sterol carriers 
is three times lower than the efficacy of low fat milk (Noakes et al., 2005). The time of day 
the phytosterols are eaten and into how many meals it is divides also changes how well they 
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lower the LDL cholesterol (Abumweis et al., 2006; Doornbos et al., 2006; Hyun et al., 2005; 
Matvienko et al., 2002; Pineda et al., 2005; Plat et al., 2000). The result for studies looking at 
the effect of the presence of unsaturated fatty acids are contradictory, as Brown et al. (2010) 
stated that saturated fatty acids in combination with phytosterols lower solubility of 
cholesterol in micelles and thus decreasing cholesterol uptake further. Micallef and Garg 
(2008), however, observed a lowering of plasma TAG, total cholesterol and HDL-cholesterol 
when patients were given n-3 long chained PUFAS and phytosterols, but not when they were 
given phytosterols together with saturated fatty acids. It thus seems as if a lower amount of 
cholesterol in the micelles, not necessarily needs to be connected with lower levels of 
cholesterol in blood.  
Some questions have arisen regarding whether or not the phytosterols present naturally in a 
diet, e.g. not added from other sources as concentrated or isolated phytosterols, have the same 
cholesterol-lowering effect as phytosterol supplements do. The dosage of phytosterols at 
which LDL cholesterol is lowered significantly depends on the type of phytosterols utilized; 
varying from 1.5g per day, if provided as sitostanol, up to 20 g per day, if provided as β-
sitosterol (Heinemann et al., 1988). Lin et al. (2010) gave one group of people a naturally 
high-phytosterol diet (449 mg phytosterols / 2000 kcal) and another one a low phytosterol diet 
(126 mg phytosterols / 2000 kcal). An increase in faecal excretion of cholesterol by up to 
79% was observed in the phytosterol abundant diets, but there were no visible effects on 
plasma LDL-cholesterol.  
Another effect of ingesting elevated levels of phytosterols, apart from lowering plasma and 
LDL cholesterol, is an increase in the ratio of liver phytosterol : cholesterol and a decrease in 
liver-cell membrane fluidity. This was shown by Leikin and Brenner (1989) in rats given high 
amounts of phytosterols (3% β-sitosterol + 2% campesterol). The effects of phytosterols on 
lipid metabolism were investigated by Laraki et al. (1993) by feeding rats diets with 12 or 24 
mg cholesterol a day and 0 - 96 mg phytosterols. The rats showed lowered liver fatty acid and 
cholesterol when the ratio of phytosterols : cholesterol was higher than 1 and in the case of 
cholesterol excess. Phytosterols are also reported to have several additional therapeutic effects 
on animals; they are anticarcinogenic (Awad et al., 2003; Rao and Janezic, 1992; Rao et al., 
1997; von Holtz et al., 1998), are anti-inflammatory (Bouic, 2001) and have anti-oxidative 
effects (Van Rensburg et al., 2000). 
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Mechanisms of phytosterols’ cholesterol-lowering effect  
The mechanisms with which phytosterols reduce plasma cholesterol are not entirely 
understood, but the parts of the puzzle are starting to fall into place with research discovering 
different ways phytosterols can affect the sterol balance in the body. Most of the theories until 
now propose that phytosterols, in some way, inhibit or diminish the uptake of cholesterol 
through the intestine. Phytosterols replace cholesterol from micelles (Brown et al., 2010; 
Matsuoka et al., 2010), and with this inhibits the uptake of dietary cholesterol. The ratio of 
phytosterols : cholesterol does, however, need to be over 1 for the micellar replacement of 
cholesterol with phytosterol to occur (Brown et al., 2010). Another theory, that has not been 
properly tested, is that the cholesterol in the intestine is made non-absorbable by the presence 
of phytosterols and phytostanols (Moreau et al., 2002). ABCG5 and ABCG8 transport 
cholesterol out of the enterocytes and into the intestinal lumen, thus preventing its absorption 
(figure 1.4), and they have been hypothesized to be connected to phytosterols‟ effect on the 
cholesterol absorption. Increased expression of ABCG5/8 has been seen when phytosterol is 
given to mice, but has been shown by using ABCG5
-/-
 mice not to be connected with the 
decreased cholesterol absorption associated with ingestion of phytosterols (Plat and Mensink, 
2002; Plösch et al., 2006).  
The transporter involved in sterol absorption, NPC1L1 (Altmann et al., 2004), suspected to be 
regulated by SREBPs (Alrefai et al., 2007), has been shown to be affected by several dietary 
factors, like PUFAs (Alvaro et al., 2010), DHA (Mathur et al., 2007) and sterols (Jesch et al., 
2009). Jesch et al. (2009) showed that cholesterol and β-sitosterol have an ability to reduce 
both transcription and protein levels of NPC1L1 in a human small intestine epithelial cell 
line, thus reducing the uptake of sterols into the enterocytes by this transporter. 
LXR has also been shown to be affected by sterols, as several phytosterols upregulates the 
expression of both LXR-α and –β (Kaneko et al., 2003; Plat et al., 2005). But since the 
ABCG5/8 has been shown to not be the target of phytosterols in the intestine, and the 
ABCG5/8 are necessary for an LXR induced reduction of cholesterol (Yu et al., 2003), it 
appears that the LXR pathway is not crucial for the plasma cholesterol-lowering effect of 
phytosterols.  
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1.4 Effects of plant derived feed on sterol metabolism in fish 
A number of experiments have been performed where the effect of vegetable oils in the diet 
to fish is investigated, and they generally show that VO can replace FO without 
compromising growth and feed utilization (Leaver et al., 2008; Miller et al., 2008; Nanton et 
al., 2007; Torstensen et al., 2005; reviewed by Turchini et al., 2009). Some studies have also 
replaced the fish meal in the feed with plant protein (PP), showing a better feed utilization, 
but lower growth because of a decreased feed intake in Atlantic salmon fed a diet with plant 
protein balanced with crystalline amino acid, compared to the ones fed marine protein (Espe 
et al., 2006). When replacing both the fish meal and fish oil with plant ingredients, lower feed 
intake, specific growth rate and lower final weight has been observed when high amounts of 
both dietary factors are replaced (80% of the fish meal and 70% of the fish oil replaced with 
plant proteins and vegetable oil, Torstensen et al., 2008).  
When changing the marine lipids in the feed with oils from other sources, the FA composition 
in the dietary lipid is reflected in the FA composition in the tissues of the fish (Jordal et al., 
2007; Nanton et al., 2007; Tocher et al., 2001; Torstensen et al., 2000; 2005), generally giving 
lower contents of highly unsaturated n-3 fatty acids (n-3 HUFA) in VO fed fish than in FO 
fed fish. Changes in lipid metabolism have been shown on several occasions to be caused by 
VO diets, often resulting in higher liver TAG when replacing FO with a VO blend (Jordal et 
al., 2007)  or linseed or soybean oil (Leaver et al., 2008).  
The increased liver TAG in VO fed fish could be connected to the low levels of HUFA in the 
VO feeds, since EPA and DHA enriched diets have been observed to decrease hepatic TAG 
synthesis (Kjær et al., 2008). The lower levels of HUFA in the VO diets is probably also the 
reason why increased activity of the desaturation and elongation of 18:3 n-3 to HUFAs has 
been observed many times in Atlantic salmon fed VO feed (Bell et al., 2001; Leaver et al., 
2008; Stubhaug et al., 2005; Tocher et al., 2001;2003). An accumulation of phytosterols in 
salmon muscle and liver is also associated with rapeseed oil based diets, as shown by Miller 
et al. (2008). Furthermore, the absorption of phytosterols in Atlantic salmon was reported to 
be poor compared to cholesterol, and some phytosterols were more efficiently absorbed and 
accumulated than others (Miller et al. 2008). 
Some effects on plasma and lipoprotein levels in salmon fed VO diets have been seen, but are 
somewhat contradictory. Jordal et al. (2007) found a significant decrease in plasma lipids and 
plasma LDL levels in VO fed fish compared to FO fed fish, whilst others found an increase in 
plasma lipid and VLDL (Torstensen et al., 2011) or did not find any significant effect of diet 
on plasma and lipoprotein composition (Torstensen et al., 2000). The study by Torstensen et 
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al. in 2011 did, however, use a feed with high inclusions of both plant protein and VO, which 
could have affected the fish more than by just replacing the lipid of their diet. In the Jordal et 
al. (2007) study the fish were given the VO diets from start feeding, something that could also 
enhance the effect of the diet change.  
VO diets for Atlantic salmon are lower in cholesterol than a traditional fish oil and fish meal 
based diet, as a regular fish meal/fish oil diet contains about 3 - 4 g cholesterol kg
-1
 feed and a 
70% VO 30% FO diet contain less than 1 g cholesterol kg
-1
 feed (Torstensen et al., in prep.). 
It seems, however, that the Atlantic salmon compensate for low cholesterol levels by 
upregulating their synthesis of cholesterol, as observed by Leaver et al. (2008) in a microarray 
study, where VO fed fish had an upregulation of genes involved in cholesterol synthesis in the 
liver than FO fed fish. They also reported an increase in expression of genes involved in 
HUFA synthesis in the VO fed fish. VO diets have also shown to lower the expression of 
LXR in Atlantic salmon, which may lead to a higher catabolism and efflux of cholesterol in 
the fish (Cruz-Garcia et al., 2009). 
Gilman et al. (2003) is one of very few studies specifically focusing on the effect of 
phytosterol on fish. They tested the effect of the main phytosterol effluent from pulp mills, β-
sitosterol, on male brook trout (Salvelinus fontinalis) and goldfish (Carassius auratus), and 
found that by giving the fish this sterol in higher concentrations through the water during 20 
days, the plasma cholesterol, LDL cholesterol, and plasma triglycerides decreased (Gilman et 
al., 2003). Some negative effects on fish health of high levels of phytosterols in the water 
have also been observed, as the phytosterol β-sitosterol functions as a hormone mimic, and 
thus affected the endocrine and reproductive functions in goldfish and rainbow trout 
(Maclatchy and Van der Kraak, 1995; Tremblay and Van Der Kraak, 1998). 
 
 
 
 
 
24 
 
1.5 Aim of the study 
The increasing need for a change from marine towards plant raw materials in aquaculture feed 
means that a carnivore species will eat vegetable oils and plant proteins to which it is not 
accustomed to. Vegetable ingredients based diets contain low levels of cholesterol, high 
levels of phytosterols and an altered fatty acid composition. The first aim of this master thesis 
was thus to elucidate the effect on sterol metabolism of Atlantic salmon when replacing FO 
with OO, RO or SO on Atlantic salmon sterol composition, when FM was maintained low. 
Low levels of dietary cholesterol and high levels of dietary phytosterols have a plasma 
cholesterol lowering effect in humans. The second aim of this master thesis was to decide if 
this is the case also in Atlantic salmon and thus giving a possible change in the cardiovascular 
health of the fish.  
1.6 Method 
The sterol metabolism is a complex mechanism and to understand it and the changes it may 
suffer because of a diet change, one has to take into consideration the absorption of sterol, 
their flux in the organism and their subsequent efflux. By choosing an array of methods, these 
three aspects of the sterol metabolism was monitored through the feeding trial. To measure 
the uptake of the sterols, a digestibility sampling was done where sterol content in faeces was 
measured, as was the gene expression of receptors for uptake of sterols in the enterocytes. 
When it comes to the metabolism and storage of sterols in the organism this was investigated 
by determining the sterol composition of liver, the main organ for maintaining sterol balance 
in many animals (Dietschy et al., 1993), and the expression of genes involved in the sterol 
metabolism. Some of the selected genes were found to be changed in their expression in 
another experiment where fish oil was replaced by vegetable oil (Leaver et al., 2008). The 
content of cholesterol and other variables in plasma and lipoprotein fractions was also 
determined, as this is an important factor concerning cardiovascular health and sterol status. 
As to the efflux of sterols, this was observed through the expression of genes coding for 
receptors that pump sterols out through the intestine and rate determining enzymes in the bile 
salt synthesis. Sterol composition was, in every case where it needed to be defined, 
determined by identification of the specific sterols by a gas-chromatographic method. 
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2. Materials and Methods 
2.1 Experimental design 
The effect on Atlantic salmon, Salmo salar, of replacing both protein and lipid in the feed 
with vegetable ingredients was investigated during 6 months on adult fish, 14 months old, to 
slaughter size. The dietary trial started the 15
th
 of April 2010 at Lerang Research Station, 
Skretting ARC, Stavanger, Norway, with a final sampling date the 15
th
 of October 2010. In 
April 2010, 600 fish with a mean weight of 815 ± 28 g (mean ± SD) were distributed equally 
in 12 tanks (50 fish per tank). The tanks had a diameter of 3m, a volume of 7000L and a flow 
between 85 - 92 L min
-1
. The mean water temperature was 9.9 ± 0.6 °C (mean ± SD).  
Atlantic salmon was fed in triplicate (n=3) with fish oil (FO) based or vegetable oil (VO) 
based feeds, all of them with a high plant protein content (figure 2.1 for basic diet designs). 
70 % of the fishmeal was replaced by plant protein sources in combination with either 100% 
fish oil or one of three oil mixes replacing 80% of the fish oil (FO) (table 2.1). The olive oil 
(OO) and soybean oil (SO) feeds contained a mixture of linseed oil and palm oil to produce a 
balanced dietary saturated-, monounsaturated- and polyunsaturated fatty acid level (SFA, 
MUFA and PUFA, respectively). The feed with rapeseed oil (RO) contained no other 
vegetable oil than RO. Plant protein sources were blended sensibly and necessary crystalline 
amino acids added to meet known amino acid requirements (National Research Council 
(U.S.), 1993). Due to a higher feed intake than predicted, a second batch of feed had to be 
made. All feed was made from the same formulation, but with a slightly different nutrient, 
fatty acid and phytosterol 
composition due to raw 
material batches being used. 
In table 2.2 the fatty acid 
composition and sterol 
content in the two feed 
batches is shown. The 
experimental feed containing 
fish oil had a high n-3 / n-6 
ratio and cholesterol level, 
but low levels of 
phytosterols compared to 
the VOs. The vegetable oil 
diets were formulated to 
FIGURE 2.1: BASIC COMPOSITION AND OILS USED IN THE EXPERIMENTAL 
DIETS. MEASURING CUPS INDICATE IF SPECIFIC DIETS CONTAIN LOW, 
INTERMEDIATE OR HIGH LEVELS OF EACH CHOSEN PARAMETER. 
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contain similarly low cholesterol levels (table 2.2.). RO was chosen for its high phytosterol 
levels, OO and SO in the feeds gave intermediate levels of phytosterols. Further, the 
vegetable oils were chosen to obtain intermediate (OO and RO) and low n-3 / n-6 ratio (SO) 
(see figure 2.1 for basic design of the diets). Palm oil was added to the SO feed, to increase 
the amount of saturated fats in the feed. Also, linseed oil and SO was added to the OO diet, to 
give a more similar fatty acid composition as in the RO diet. 
Because of a higher feed intake than predicted, a second feed batch had to be made during the 
feeding trial. Fish were fed batch 1 diets from the 15
th
 of April till the 1
st
 of September, and 
then batch 2 was introduced from 1
st
 of September to the 15
th
 of October. 
TABLE 2.1: FORMULATION AND PROXIMATE COMPOSITION OF EXPERIMENTAL FEEDS 
 FO OO RO SO 
Ingredients (g kg-1)         
Fish meal1 180 180 180 180 
Wheat gluten2 162.3 162.3 162.3 162.3 
Hi-pro soya3 97.3 97.3 97.3 97.3 
Soya concentrate4 150 150 150 150 
Wheat 5 70 70 70 70 
Fish oil6 309.9 62 62 62 
Rapeseed oil 7 - - 248 - 
Olive oil 8 - 208 - - 
Soybean oil 9 - 20 - 217.9 
Palm oil 10 - - - 30 
Linseed oil11 - 20 - - 
Premixes12 31.8 31.8 31.8 31.8 
Total weight, g 1001.3 1001.3 1001.3 1001.3 
Yttrium oxide  premix13 1.0 1.0 1.0 1.0 
 Batch 
1 
Batch 
2 
Batch 
1 
Batch 
2 
Batch 
1 
Batch 
2 
Batch 
1 
Batch 
2 
Composition,  g 100 g-1         
Fat 35.6 34.1 34.6 33.6 34.2 34.5 35.0 33.2 
Protein 40.6 41.1 40.5 40.8 41.3 41.3 39.8 40.6 
Moisture 6.6 6.8 6.1 6.9 6.3 6.4 6.3 6.6 
Ash 5.2 5.3 5.1 5.2 5.2 5.2 5.2 5.2 
 
 
 
 
 
 
 
 
1 South American fish meal, Skretting, Stavanger, Norway 
2 Cargill Nordic, Charlottenlund, Denmark 
3 Felleskjøpet, Stavanger, Norway 
4 Imcopa, Araucaria, Brazil 
5 Skretting, Stavanger, Norway 
6 Northern hemisphere fish oil, Skretting, Stavanger, Noway 
7 Skretting, Stavanger, Norway 
8 D. Danielsen AS, Stavanger, Norway 
9 Denofa AS, Fredrikstad, Norway 
10 Fritex 24, Aarhus Karlshamns, Karlshamn, Sweden  
11 Elbe Fetthandel GmbH, Geesthacht, Germany 
12 Include vitamins and minerals; Trouw Nutrition, Boxmeer, the Netherlands, 
proprietary composition Skretting ARC 
13 Contains 10% Yt2O3,  Treibacher Auermet, Althofen, Austria 
 
27 
 
TABLE 2.2: FATTY ACID COMPOSITION AND STEROL CONTENT IN EXPERIMENTAL DIETS 
  FO OO RO SO 
Fatty acids  Batch Batch Batch Batch Batch Batch Batch Batch 
(area %)  1 2 1 2 1 2 1 2 
14:0            7.4 6.8 1.4 1.5 1.8 2.0 1.5 1.7 
16:0            18.4 15.9 12.3 12.4 7.9 7.8 15.1 14.8 
18:0            3.7 2.9 3.4 3.3 2.6 2.5 3.7 3.8 
Total saturated FA 31.8 26.8 19.0 18.0 14.4 13.2 22.3 21.2 
16:1n-7          6.9 5.9 1.7 1.9 1.8 1.8 1.3 1.5 
18:1n-7          2.2 2.0 1.8 2.2 2.9 2.7 1.7 1.6 
18:1n-9          9.7 11.9 50.2 50.3 44.2 42.7 22.0 21.5 
20:1n-9          3.8 5.6 1.0 1.4 1.8 2.4 0.9 1.4 
22:1n-9          0.4 0.6 0.1 0.1 0.2 0.4 0.0 0.1 
22:1n-11         6.2 10.2 1.1 2.0 1.4 2.8 1.1 2.2 
Total monoene FA 30.3 38.5 56.1 58.4 52.4 53.5 26.9 28.6 
18:2n-6 2.6 2.7 13.7 12.1 17.3 15.8 40.1 37.5 
20:3n-6          0.0 0.9 0.0 1.0 0.0 1.1 0.0 1.3 
20:4n-6          1.1 0.5 0.2 0.1 0.2 0.2 0.2 0.1 
18:3n-3 1.1 1.4 4.6 4.1 8.3 7.8 4.9 4.4 
18:4n-3            2.6 2.6 0.5 0.5 0.6 0.7 0.5 0.6 
20:4n-3          0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 
20:5n-3            11.0 8.1 2.2 1.9 2.7 2.5 2.1 2.0 
22:5n-3            2.0 1.1 0.4 0.3 0.5 0.3 0.4 0.3 
22:6n-3            8.9 10.0 1.9 2.3 2.3 3.0 1.7 2.4 
Sum n-3 29.1 24.9 10.5 9.5 15.2 14.8 10.2 10.1 
Sum n-6 4.4 4.7 13.9 13.2 17.5 17.2 40.3 39.0 
Sum EPA & DHA 20.0 18.1 4.1 4.2 4.9 5.4 3.8 4.5 
Sum PUFA 34.3 30.1 24.6 22.8 32.9 32.2 50.6 49.3 
n-3/n-6 6.7 5.3 0.8 0.7 0.9 0.9 0.3 0.3 
Sterols (mg kg-1 feed)            
Cholesterol 2110.7 2576.2 759.7 909.9 939.7 1114.5 773.1 967.6 
Brassicasterol 10.8 57.2 6.0 3.5 195.3 170.1 3.5 0.2 
Campesterol 76.3 60.9 170.1 113.1 881.4 583.0 231.3 174.3 
Campestanol 19.7 17.5 21.5 21.1 21.4 75.2 25.8 24.6 
Stigmasterol 10.2 9.2 38.2 30.5 13.5 17.4 136.8 106.6 
β-Sitosterol 208.6 143.3 733.5 564.4 1218.4 821.5 574.1 439.6 
Sitostanol 32.4 27.5 123.9 171.8 128.2 183.8 74.9 46.9 
Stigmasta-5,24-dienol 0.0 0.0 6.1 10.3 13.4 6.1 9.7 5.1 
Stigmast-7-enol 10.6 2.6 175.7 129.5 47.5 6.2 76.0 64.4 
Delta-7-avenasterol 3.5 0 4.7 0 6.7 9 15.4 12.6 
Total phytosterol 372.1 318.2 1279.7 1044.2 2525.8 1872.3 1147.4 874.3 
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2.2 Sampling 
All the experimental feeds were sampled and stored at -20 °C till the moment of analysis. 
There were three samplings of the experimental fish: one before the fish were fed the 
experimental feed, 09
th
 of April 2010, one approximately eleven weeks later, 23 - 24
th
 of June 
2010, and one at the end of the feeding trial, 19 - 21
st
 of October 2010 . In addition to this a 
digestibility sampling was performed at about T = 22 weeks. The final meal prior to the 
samplings was 24 hours at the initial and second sampling and 48 hours prior to the final 
sampling. This change in starvation time was due to observed feed in the digestion tract of the 
fish in the second sampling. The salmon were anaesthetized with MS222 at a concentration of 
7 g L
-1
, killed by a blow to the head and individually weighed and measured.  
Initial Sampling: 
The first sampling was done before the feeding experiment started. Three random samples 
were taken from the whole experimental fish population. Liver samples for analysis of 
phytosterols were collected from five fish (n = 3), pooled and homogenized and stored on dry 
ice. For the plasma samples, blood from five fish per tank was collected and centrifuged, 
plasma was pooled to obtain one sample per tank, and then stored on ice/refrigerator until 
separated into lipoprotein fractions (n = 3). 
Intermediate and final Sampling: 
The intermediate and final samplings were similar except from the starvation time (see above, 
under Sampling). 
For the RNA samples, three fish from each tank were sampled and ca 1 g of liver per fish was 
individually put in eppendorf tubes and immediately frozen on liquid nitrogen. The same 
procedure was followed for the midintestine samples for RNA analysis. For the plasma 
samples, blood from five fish per tank was collected and centrifuged together, further 
treatment of plasma samples as in initial sampling. Liver samples for analysis of phytosterols 
were collected from five fish per tank, in the same manner as in initial sampling.  
Digestibility sampling: 
The 8
th
 of September 2010, pooled samples of faeces from three fish per tank were taken by 
opening the intestine of the fish and taking faeces out of the hind gut (n = 3). The fish were 
fed 12 hours before the sampling, resulting in digested feed in the hind gut.  
The samples from all the samplings were stored at -80 °C until further analysis.  
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2.3 Dietary proximate, fatty acid and lipidclass composition 
Diets were analyzed for the content of dry matter, crude protein, total lipid and fatty acids, 
phytosterols, starch, gross energy, ash and yttrium oxide. Dry matter in the diets was 
measured gravimetrically after freeze-drying of homogenized samples for 48 h.  Ash was 
determined gravimetrically after flame combustion at 550 °C until constant weight. Total 
nitrogen was determined on homogenized, freeze-dried samples using a nitrogen determinator 
(LECO, FP-428 system 601-700-500; Perkin Elmer Coop., CT, USA; crude protein: 
N × 6.25). Energy content was measured by bomb calorimetry (Parr 1271, Parr, Moline, IL, 
USA). Yttrium was analyzed by dissolution of ashed samples with hydrochloric acid and 
nitric acid by heating, and then dissolved in 5% nitric acid. Yttrium was then detected with an 
ICP-AEF, Optima 3000 V (Perkin Elmer, USA). Total lipid of the diets was measured 
gravimetrically after ethyl acetate extraction and after acid hydrolysis of the diet samples.  
For analysis of fatty acids, lipids from the samples were extracted by adding 
chloroform/methanol (2:1, v/v). After extraction of lipids, the samples were filtered, an 
aliquot was removed for determining lipid class composition as described below, and then the 
remaining samples were saponified and methylated using 12% BF3 in methanol. Fatty acid 
composition of total lipids was analysed using methods described by (Lie and Lambertsen, 
1991) where the methyl esters were separated using a Trace gas chromatograph 2000 (Fison, 
Elmer, USA) („cold on column‟ injection; 60 °C for 1 min 25 °C min-1, 160 °C for 28 min 25 
°C min
-1
, 190 °C for 17 min 25 °C min
-1
, 220 °C for 10 min), equipped with a 50-m CP-sil 88 
(Chromopack) fused silica capillary column (id : 0.32 mm). The fatty acids were identified by 
retention time using standard mixtures of methylesters (Nu-Chek, Elyian, USA), and the fatty 
acid composition (area %) were determined. All samples were integrated using the 
Totalchrom software (ver. 6.2, Perkin Elmer) connected to the Gas Liquid Chromatography 
(GLC). Amount of fatty acid per gram feed was calculated using 19:0 methyl as internal 
standard. 
The quantification of lipid class composition in diets and liver was determined by high-
performance thin-layer chromatography (HPTLC) as described by Bell et al. (1993).Ten 
microgram total lipid was applied to a 10 cm · 20 cm HPTLC plate that had been prerun in 
hexane : diethyl ether (1 : 1 v/v) and activated at 110 °C for 30 min. The plates were 
developed at 5.5 cm in methyl acetate, isopropanol, chloroform, methanol and 0.25% (w/v) 
aqueous KCl (25 : 25 : 25 : 10 : 9, by volume) to separate phospholipid classes with neutral 
lipids running at the solvent front (Vitello and Zanetta, 1978). After drying, the plates were 
developed fully in hexane, diethyl ether and acetic acid (80 : 20 : 2, v/v/v) to separate neutral 
30 
 
lipids and cholesterol. Lipid classes were visualized by charring at 160 °C for 15 min after 
spraying with 3% copper acetate (w/v) in 8% (v/v) phosphoric acid identified by comparison 
with commercially available standards. Lipid classes were quantified by scanning 
densiometry using a CAMAG TLC Scanner 3 and calculated using an integrator (WinCATS-
Planar Chromatography, Version 1.2.0). Further, quantitative determination (mg lipid class g
-1
 
tissue) of lipid classes was performed by establishing standard equations for each lipid class 
within a linear area, in addition to including a standard mix of all the lipid classes at each 
HPTLC plate for corrections of between plate variations. 
 
2.4 Analysis of sterol content 
Analysis of phytosterol and cholesterol contents in liver, faeces and feed was performed with 
gas chromatography as described by Laakso (2005).  500 µl of internal standard, 5-β-
cholestan-3-α-ol dissolved in isopropanol to 0.6 mg ml-1, was measured and dried on a 
heatblock (max. 80 ˚C) with nitrogen flow. The sample was added, exactly about 200 mg of 
sample if liver; 400 mg if feed; 50 mg if faeces or 20-30 mg if control material, in this case 
phytosterol enriched margarine of the brand vita pro-aktiv (Mills DA). All the samples except 
faeces were analyzed without prior freeze-drying. 
To saponify the samples 2.5 mL of 2 M KOH solution was added and the tube was put in an 
ultrasonic bath for an hour at 65-75 ˚C. When chilled to room temperature, 2 mL of water and 
3 mL of hexan was added and centrifuged one minute at 3000 rpm. The hexan phase was 
collected and the extraction process repeated with 3mL hexan. The extract was dried on 
heatblock (max. 70 °C) with nitrogen flow and then derivatized to trimetyl silyl ether of 
sterols by adding 100 µl pyridine and 200 µl silylation reagent (Bis[trimethylsilyl]-
trifluoracetamid with 1% trimethylchlorosilane) and warmed on a heatblock at 70 °C for 15 
min. The samples were diluted 20x in hexan before analysis on GC. 
The following instrumentation was used:  Thermoquest trace GC 2000 with an autosampler 
AS2000 (Thermo Finnigan Quest), on-column injector, flame ionization detector and the 
column Equity
®
 with dimensions 530 m*0.25 mm i.d. (Supelco, Bellefonte, USA). This is not 
the classic phytosterol-column (which has an internal diameter of 0.32 mm), but it has in the 
NIFES laboratory shown to give better separation of the phytosterols although it is more 
sensitive to overloading than the classical one. Helium was used as a carrier gas at 0.9 ml 
min
-1
, hydrogen and air were used as detector gases at 35 and 350 ml min
-1
, respectively. 
Temperature started at 100 °C, increased by 50 °C min
-1
 to 300 °C and kept for 12 minutes. 
The peaks were identified with the software Chromeleon
®
 version 6.8. 
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 2.5 Separation of lipoproteins  
Separation of lipoproteins was performed by centrifugal flotation as described by Jordal et al. 
(2007). Potassium Bromide was added to obtain the density intervals of the different 
lipoproteins. The instrument used was a Beckman Optima XL-100K set to 197600 · gav and 4 
˚C in all steps of the separation process. The following centrifuge times and densities were 
used for the separation: VLDL 1.015 g mL
-1
 20 hours; LDL 1.085 g mL
-1
 20 hours; HDL 
1.21g mL
-1
 44 hours. The remaining fraction was called non-lipoprotein fraction (NLP).  All 
the fractions were weighed and immediately frozen at -80 ˚C.  
2.6 Plasma and lipoprotein composition 
Plasma and lipoprotein were analyzed using a clinical bioanalyzer (Maxmat PL analyzer, 
Montpellier, France) according to standardized procedures, reagents and controls to find 
contents of Alaninaminotransferase (ALAT), Aspartataminotransferase (ASAT), cholesterol, 
glucose, protein and triglycerides. All the reagents, controls and the calibrator solution were 
from MaxMat S.A. (Montpellier, France). The used reagents were ALAT/GPT 500, 
ASAT/GOT 1500, Cholesterol 1600, Glucose PAP 800, Total protein 600 and Triglycerides 
2000. The control solutions were Maxtrol P (abnormal multiparametric control) and Matrol N 
(normal multiparametric control). The calibrator was the multiparametric calibrator MaxCal.  
2.7 Real-time Quantitative PCR (qPCR) 
-Development of qPCR assay 
Primers were designed for the genes ACAT2, CYP7A1, ABCG5, and NPC1L1, the LXR 
primer was found in the PhD thesis of Lourdes Cruz-Garcia (2010), whereas the other primers 
were previously presented by Leaver et al. (2008) and Torstensen et al. (2011). 
The mRNA sequences for ABCG5, ACAT2, and CYP7A1 from zebra fish, Danio rerio were 
found on the NCBI database, the sequences for HMGR and NPC1L1 were found in the 
human genome. Using a BLAST tool searching in the nucleotide selection, mRNA sequences 
from Salmo salar were found for ACAT2 and CYP7A1. For the rest of the genes, sequences 
from rainbow trout, Oncorhynchus mykiss, were used (table 2.3 for accession numbers).  
Using the online primer designing program primer3 (Rozen and Skaletsky, 2000), primers 
were designed from the reading frame sequence when available, found in the NCBI database. 
The three best constructs recommended by primer3 were selected and ordered from  
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TABLE 2.3: GENES, ACCESSION NUMBERS, AND VARIOUS INFORMATION ABOUT THE PRIMERS USED FOR QPCR 
 
Gene name 
 
Accession N° 
 
Amplicon 
size, BP 
Anneal. 
Temp., 
°C 
 
Forward Sequence 
 
Reverse Sequence 
 
Tissue 
Mean  
efficiency  
of qPCR 
ACAT-2 NM001139949.1 207 60 CAGATGGTGTGTGGATCTGG GCAGTGGAAAGCATCAGTCA Liver 1.63 
Apo A-1 CB506105 73 60 CCATCAGCCAGGCCATAAA TGAGTGAGAAGGGAGGGAGAGA Liver 1.79 
Apo B-100 gi:854619 121 60 TTGCAGAGACCTTTAAGTTCATTCA TGTGCAGTGGTTGCCTTGAC Liver 2.76 
Apo C-2 DN047858 145 60 GGAACCAGTCGCAGATGTTGA TGAGGACATTCGTGGCCTTC Liver 1.75 
CYP7A1 BT059202.1 178 60 GAAGACCTTGCAGGGTGAAG GCCGAAGAGTGTCAGGTAGC Liver 2.18 
DHCR7 TC99602 230 60 CTTCTGGAATGAGGCATGGT -ACAGGTCCTTCTGGTGGTTG- Liver 1.82 
LDLR AJ003118 78 60 GCATGAACTTTGACAATCCAGTGTAC TGGAGGAGTGCCTGCTGATAT Liver 1.84 
MVK EZ861975.1 243 60 GCCTGCAACCGTAGGTATGT AAGAGTGCCGACAGCTTCAT Liver 1.74 
SREBP2 DY733476 225 60 GACAGGCACAACACAAGGTG CAGCAGGGGTAAGGGTAGGT Liver 2.13 
HMGR DW561983 224 60 CCTTCAGCCATGAACTGGAT TCCTGTCCACAGGCAATGTA Liver 2.06 
LXR NM001159338 171 60 TGCAGCAGCCGTATGTGGA GCGGCGGGAGCTTCTTGTC Liver 2.13 
ABCG5 EZ885222.1 165 60 CATGGTCAACACAGGAGTGG AGGCCATGGAACTCTGTGAC Intestine 2.04 
NPC1L1 EZ788198.1 178 60 GATGGAATAGAGCCGACAGC GGGTATGAATGCAACCTGCT Intestine 2.31 
β-actin 
(Reference gene) 
BG933897 91 60 
CCAAAGCCAACAGGGAGAAG 
AGGGACAACACTGCCTGGAT Ref. gene Liver: 2.18 
Intestine: 2.00 
E1ab    
(Reference gene) 
BG933853 59 60 TGCCCCTCCAGGATGTCTAC CACGGCCCACAGGTACTG Ref. gene Liver: 2.12 
Intestine: 2.14 
 
33 
 
Invitrogen. All the ordered primers had a melting point of approximately 60.0 ˚C and a 
product size range between 150 and 250 basepairs. The efficiencies of the primerpairs were 
between 1.63 and 2.76. The melting point, product size and efficiency of each primer are 
shown in table 2.3. The two reference genes, β-actin and Elongation factor 1ab (E1ab), were 
selected based on previous verification by Olsvik et al. (2005).  
-One-Step PCR 
To verify the efficacy of the primers developed, a one-step PCR was performed. In this 
reaction, all the reagents needed for a RT-reaction and a PCR were added to have both these 
reactions in only one step. A master mix was made using the QiaGen Onestep RT-PCR kit 
and RNase inhibitor was added. The temperature cycler used was a GeneAmp
®
 PCR System 
9700 (Applied Biosciences). The PCR was done by starting at 50 °C for 30 minutes for the 
reverse transcriptase, then 15 min at 95°C for PCR activation, 33 cycles followed with 45 s 
denaturation at 94 °C, 45 s annealing at 55 °C, 1 min elongation at 72 °C and a 10 min final 
extension at 72 °C. 
 
The PCR product was run on a 1% agarose gel, using GelRed
TM
 Nucleic Acid Stain (Biotium) 
as a dye and a 50 bp DNA ladder from Biolabs. The current was set to 80 V and the running 
time about an hour. The following primers were tested: ABCG5, ACAT2, CYP7A1, MVK 
and NPC1L1. 
-RNA isolation 
Liver and midintestine samples from individual fish (n = 9 per dietary treatment) was 
homogenized in Trizol by using zirconium beads (4 mm) in a Retsch MM 310 homogenizer 
(Retsch GmbH, Haan, Germany). Subsequent addition of chloroform separates RNA from 
proteins and DNA. RNA was then precipitated from the water phase by adding isopropanol. 
Further on, the RNA pellet was cleansed two times in ethanol which then was dissolved in 
RNase free water. A DNAse treatment with DNA-free
TM
 was performed on the RNA extract 
to remove the DNA that might be present. The final concentration of RNA was measured 
with the Nanodrop ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE, USA). To check the quality of the RNA 12 random samples were selected 
and tested with RNA6000 Nano LabChip kit, run on the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Palo Alto, CA, USA). The quality was satisfactory, with an RNA Integrity 
Number (RIN) between 9.4 - 10 for the liver samples and 7.6 - 9.7 for intestine. The RNA 
extracts were frozen at -80 ˚C and stored until RT-qPCR and qPCR was performed. 
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-Reverse transcription-PCR and Real-time Quantitative PCR 
Reverse transcription-PCR (RT-PCR)  
The standard curve was made from twofold serial dilutions of a “RNA-pool”, a mix of an 
equal amount all the samples on the plate. Six serial dilutions (1000-31 ng) were made in 
triplicates in separate wells on the 96 well plate. The 36 samples from each tissue in 
duplicates were analyzed on the same plate and the amount of RNA in each well was 500 ng. 
Negative controls, made from the “RNA-pool”, were non-amplification control without 
enzymes (nac) and non-template control with RNase free water instead of RNA (ntc). The RT 
reaction mix was made with the kit TaqMan reverse transcription reagents (Applied 
Biosystems, Foster City, CA, USA). The final concentrations in the RT mix were: Taqman 
RT buffer (1X), magnesium chloride (5.5 mM), 1deoxyNTPs Mixture (500 µM per dNTP), 
oligo d(T)16  (2.5 µM), RNase inhibitior (0.4 U µL
-1
), Multiscribe reverse transcriptase (1.67 
U µL
-1
). 50 µL reverse transcription reactions were performed during 60 min at 48 °C with 
the PCR system GeneAmp PCR 9700 (Applied Biosystems, Foster City, CA, USA). The 
finished RT plates were stored at -80 °C until real-time quantitative PCR was to be run. 
 
Real- time quantitative PCR (qPCR) 
The RT plates were defrosted on ice and added RNase free water (1:1 v/v), spun down for 1 
minute at 700 rpm and vortexed for 5 minutes at 1500 rpm. A SYBR
®
 Green master mix 
(Roche Applied Sciences, Basel, Switzerland), which contains gene-specific primers was 
prepared on a RNA/DNA free room. 8 uL of the master mix was added to each well on a 384 
well plate together with 2 uL RNA by a pipetting robot (Biomek
®
 3000, BeckmanCoulter). 
The plate was spun down, 1500 rpm during two minutes, and run in the Light Cycler 480 
Real-Time PCR System (Roche Applied Sciences, Basel, Switzerland). The PCR was 
accomplished with a denaturation and enzyme activation at 95 °C for 5 min, followed by 40 
cycles of the amplification process which consisted of 10 s denaturation at 95 °C, 20 s 
annealing at 60 °C and 30 s elongation at 72 °C. A melting curve analysis was performed to 
make sure only one gene product was produced in the PCR reaction. This was done by 
maintaining 95 °C for 5 s, then 1 min at 65 °C and finally increasing the temperature to 97 °C. 
The total time of the real time Q-PCR, included final cooling, was 51 min 15 s. The software 
Lightcycler
®
 480 software, version 1.5.0.39, was used for calculating standard curves and 
efficiency of the reaction. 
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2.8 Statistical analysis and calculations 
For the statistical work with the results, the free software environment R was used (R 
Development Core Team, 2010). One-way ANOVA was performed on the data on liver and 
plasma sterols, followed by multiple comparisons using Tukey–Kramer HSD (Hothorn et al., 
2008). The data were analyzed for homogeneity in variance using a Levene‟s test and for 
normality using a Shapiro Wilk‟s test. Linear mixed effects models (Pinheiro et al., 2010) 
were used for the genetic expression and growth results, to be able to take into account the 
cluster effect each tank has on the individual results. For these results the normality of the 
residuals and their constant variance from the model was confirmed by graphical analysis. 
Examples of plots used for this analysis are given in the appendix (figure A.1 and A.2). Data 
are given as mean ± SD, and a significance level of 5% was used (p < 0.05) unless otherwise 
stated. 
The stability of the expression of each reference gene was calculated from the Ct values by 
using the program geNorm (Vandesompele et al., 2002) according to the geNorm manual. 
GeNorm determines the stability of each gene within a pool of genes, given as the M value. A 
normalization factor is made from the geometrical mean by a pairwise comparison of the 
expression profile of the genes. The M values of both the reference genes were satisfactory, 
0.40 - 0.75, when all 36 samples from each tissue were evaluated together. Both of the 
reference genes were thus included in the normalization factor. The normalized expression of 
the genes was calculated by dividing each Ct value by its respective normalization value. 
The apparent digestibility coefficients (ADC) were calculated as: ADC (%) = 100 - 
[100((Ydiet/Yfaeces) * ((STfaeces/STdiet))], where Y is the percentage of yttrium oxide and ST the 
percentage of particular sterols. Yttrium oxide has been shown to be valid for this type of 
digestibility experiment by Carter et al. (2003). The calculation does not take into 
consideration the possible dealkylation of phytosterols to cholesterol (Miller et al., 2008). 
 
2.9 Methodological considerations 
 Validity of PCR data 
In modern qPCR there are still some dubieties as to which methods are the most correct, 
especially regarding methods of quantification and normalization of output from the reaction 
(Adams, 2006). Guidelines have, however, been established for how to perform an optimal 
qPCR in order to have more comparable results throughout the scientific community and 
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which information that should be reported when publishing  (Bustin et al., 2009; 2010). 
Considerations to be made when performing PCR are discussed below. 
Quantification 
The method used for quantification of this qPCR reaction is based on fluorescence of SYBR 
Green
®
, which increases its fluorescence when bound to double-stranded DNA. There is no 
need for a probe in this method, which reduces costs, but the disadvantage is that SYBR 
Green
®
 is unspecific in its ds-DNA binding and may give false positive signals. Another thing 
to have in mind when using DNA dyes as this is that they may bind several times to every 
DNA chain depending on their length, but having approximately the same length of all the 
amplified sequences reduces this error (Applied Biosystems, 2011). If the RNA Integrity 
Number (RIN) is insufficient the samples could also come out as a negative (Sproul, 2006). 
The efficiency of the qPCR is ideally 2.0, as this is the number of molecules synthesized from 
every template in the exponential phase of the reaction. The SYBR Green assay is known for 
showing some inhibition, hence possibilities of giving efficiencies over 2.0. An efficiency of 
at least 80% (e.g. 1.6) is advised by Wang and Seed (2006).  
Normalization 
For optimal results from qPCR, an appropriate normalization should be done to control for 
experimental error (Pfaffl, 2006; Vandesompele et al., 2002). To get reliable results when 
normalizing data from PCR, a similar sample size should be used for all samples and one 
should ensure that the amount of RNA in each well is the same. There is also a need for 
verifying the quality of the RNA as degraded RNA may affect results severely (Bustin and 
Nolan, 2004).  
In this experiment the amplicons had approximately the same length, there was the same 
amount of RNA in each well and the quality of the RNA was verified and acceptable. This is 
in accordance with the current guidelines (Bustin et al., 2009; 2010), and should have reduced 
the possible errors in the qPCR performed. 
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3. Results 
3.1 Dietary sterols 
The feeds were analyzed for sterol contents, 
and the mean sterol levels of the two feed 
batches made is presented in figure 3.1 (exact 
values for each feed batch are given in table 
2.2). The rapeseed oil (RO) feed is the 
formulation with the highest content of 
phytosterols, the fish oil (FO) based feed the 
one with the highest cholesterol content. The  
mean ratio phytosterol:cholesterol in the two  
feed batches were 0.15, 1.42, 2.18 and 1.19 for 
the FO, OO, RO and SO feed, respectively. 
 
TABLE 3.1: RELATIVE COMPOSITION OF PHYTOSTEROLS IN THE EXPERIMENTAL DIETS (WT%) AND TOTAL FEED 
INTAKE IN GRAMS PER FISH DURING EXPERIMENTAL TRIAL (MEAN±SD). SIGNIFICANT DIFFERENCES BETWEEN 
DIEATRY GROUPS  IN FEED INTAKE DENOTED BY DIFFERENT LETTERS (T-TEST, P<0.05). 
 
 
 
 
 
 
 
 
 
 
The three vegetable oil (VO) based feeds had a similar content of cholesterol per kg, but the 
FO feed had between 2.3 and 2.8 times more cholesterol per kg than the VO feeds (figure 3.1 
and table 2.2). The main phytosterols present in the FO feed were β-sitosterol and 
campesterol at 50.5% and 19.8% of total phytosterols, respectively (table 3.1).  In the olive oil 
(OO) feed phytosterols made out 58.1% of total sterols, β-sitosterol and campesterol being the 
main ones at 52.0% and 15.5% of total phytosterols, respectively. High contents of β-
sitosterol and campesterol also characterized the RO and soybean (SO) based feeds, although 
the RO feed contained 7.7% more campesterol and 16.4% less β-sitosterol than the SO feed 
(table 3.1). The RO feed contained the highest ratio of phytosterol/total sterol at 73% and 
 Fish oil Olive oil Rapeseed oil Soybean oil 
Brassicasterol 10.4 0.3 8.4 0.2 
Campesterol 19.8 15.5 33.0 16.6 
Campestanol 5.4 2.1 2.4 2.2 
Stigmasterol 2.8 7.4 0.7 7.6 
β-Sitosterol 50.5 52.0 46.1 53.8 
Sitostanol 8.7 11.5 7.4 7.5 
Other phyto. 2.3 11.1 1.9 12.0 
Total phyto. 100.0 100.0 100.0 100.0 
Feed intake, g 2982 ± 79a 2748 ± 169ab 2759 ± 91ab 2573 ± 115b 
FIGURE 3.1: MEAN PHYTOSTEROL AND 
CHOLESTEROL, MG KG-1, OF THE TWO FEED 
BATCHES. FO: FISH OIL. OO: OLIVE OIL, RO: 
RAPESEED OIL, SO: SOYBEAN OIL.  
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63% of total dietary sterols in batch 1 and 2, respectively.  Dietary fatty acid compositions 
were close to identical in the two feed batches for all the experimental feeds (table 2.2). 
Dietary cholesterol contents were higher for all the feeds in batch 2 than in batch 1, being on 
average 21% higher in feed batch 2 than in feed batch 1 , whereas the phytosterol levels were 
lower in batch 2 than in batch 1 (15% lower in the FO, 18% lower in OO, 26% lower in RO 
and 24% lower in the SO diet, table 2.2). 
3.2 Growth & feed intake 
The fish started out with an average weight of 
815 ± 28 g, and after 28 weeks of feeding the 
weight was 3395 ± 534 g (figure 3.2). The mean 
length and condition factor at the final sampling, 
T = 28 weeks, were 59 ± 3 cm and 1.60 ± 0.15, 
respectively. There were no significant 
differences in weight, length or condition factor 
between the dietary groups in the final sampling, 
although the soybean oil (SO) fed fish were 
slightly shorter than the other fish and nearly 
significantly shorter than the FO fed fish (p = 
0.066) with a mean length of 60.2 cm in the FO 
group and 58.9 in the SO group.                 
The mean feed intake for all the dietary groups throughout the dietary trial was 2765 ± 182 g 
per fish (table 3.1), being significantly larger in the FO group than the SO group. The mean 
weight gain per fish was 2558 ± 79, 2655 ± 164, 2683 ± 90, 2442 ± 99 in the FO, OO, RO 
and SO group, respectively. The SO group had a slightly smaller weight gain than the other 
groups, being significantly smaller then the RO group (p = 0.035, t-test). The data for sterol 
amounts in feed were used together with the growth data for calculating the amount of sterols 
each fish consumed per gram of weight gain through the feeding trial (figure 3.3). The sterol 
ingested per gram of weight gain reflects the cholesterol and phytosterol composition in the 
feed (figure 3.1). 
The feed conversion ratio (FCR) and specific growth rate (SGR) was calculated for all the 
dietary groups. The FO group had the highest FCR of all the dietary groups, being 
significantly higher than the VO groups (p < 0.001). The FCR value for FO was 1.17 ± 0.03 
and 1.04 ± 0.01 in the VO groups. SGR values for FO, OO, RO and SO were 0.75 ± 0.02, 
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FIGURE 3.2: BODYWEIGHT DURING THE 28 
WEEKS OF THE DIETARY TRIAL, MEAN VALUES 
FOR EACH DIETARY GROUP ± SD 
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0.78 ± 0.01, 0.79 ± 0.03 and 0.74 ± 0.01, respectively, and was significantly lower in SO 
compared to both OO and RO (p = 0.02 and p = 0.05, respectively, t-test). 
 
 
 
3.3 Cholesterol in liver 
There was a tendency of RO fed Atlantic salmon having lower liver cholesterol after 11 
weeks of feeding than all the other dietary groups (figure 3.4a), but there was only a 
significant difference between the RO and the SO group (p = 0.04). At the final sampling, e.g. 
after 28 weeks, the liver cholesterol levels were significantly higher in the OO and SO group 
compared to the FO group, with OO containing 3073 ± 35 and SO 3052 ± 66 mg cholesterol 
per kg liver tissue and the FO fed fish 2844 ± 56 mg cholesterol per kg liver tissue. Due to 
non-homogeneity in the variance of the data a t-test was performed instead of an ANOVA in 
this case, which told us that the OO and SO groups were significantly different from the FO 
group (p = 0.007 and p = 0.015, respectively, figure 3.4b). The content of cholesterol in the 
RO group at the final sampling was varying, ranging from 2742 and 3028 mg kg
-1 
(figure 
3.4b). A significant increase in liver cholesterol levels was seen from the initial sampling to 
the final sampling for all the groups (p < 0.008, t-test) except for the RO group where the 
variance was very big and thus the changes not significant (figure 3.5). The RO group shows 
a different behaviour in its liver cholesterol levels than the other groups, as it has a clear 
decrease from the initial to the second sampling (p < 0.001, t-test) which is not present for the 
other groups (figure 3.5).  
 
FIGURE 3.3: MG CHOLESTEROL AND 
PHYTOSTEROLS INGESTED PER 
GRAM WEIGHT GAIN IN ATLANTIC 
SALMON FED DIFFERENT 
EXPERIMENTAL FEEDS DURING 28 
WEEK. DATA ARE PRESENTED AS 
MEAN ±SD (N=3). SIGNIFICANT 
DIFFERENCES ARE DENOTED BY 
DIFFERENT LETTERS. 
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From the second to the final sampling all the dietary groups had a significant increase in liver 
cholesterol (p < 0.001, t-test; figure 3.5). Even though FO was the group with the highest 
levels of cholesterol in the feed, it was the group that had the smallest increase in liver 
cholesterol from the initial to the final sampling. The biggest increase in liver cholesterol 
from the intermediate to the final sampling was seen in the RO group (+467 mg kg
-1
 tissue), 
closely followed by OO (+426 mg kg
-1
) and SO (+344 mg kg
-1
). The FO group had the 
smallest change in liver cholesterol from the intermediate to the final sampling (+219 mg kg
-
1
) and also had the lowest cholesterol levels in the liver at the final sampling at 2844 ± 56 mg 
kg
-1
. The OO and SO fed groups had the highest levels of liver cholesterol at the final 
sampling, with 3073 ± 35 and 3052 ± 66 mg kg
-1
, respectively. 
To look for effects of phytosterols in feed on cholesterol levels in liver, only the VO groups 
were used for the calculations as they have approximately the same cholesterol levels. By 
excluding the FO group from these calculations, one makes sure that it is only the effect of 
phytosterols in feed one investigates, and not the possible effect the cholesterol in feed might 
have on the cholesterol levels in the liver. A correlation of -0.72 between the phytosterol in 
feed and the cholesterol amounts in liver indicates that an increasing phytosterol amount in 
the feed is connected to decreasing amounts of cholesterol in liver when considering both 
samplings (figure 3.6).  
 
FIGURE 3.4: CHOLESTEROL CONTENTS IN LIVER SAMPLED FROM ATLANTIC SALMON FED DIFFERENT OILS IN 
DIET, SAMPLED AFTER A: 11 WEEKS AND B: 28 WEEKS. VALUES PORTRAYED ARE THE STANDARD BOX-AND-
WHISKER PLOT IN R, I.E. MEDIAN, AND FIRST AND THIRD QUARTILE (Q1 AND Q3). WHISKERS ARE MIN. AND 
MAX. VALUES. STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE DENOTED BY DIFFERENT LETTERS. 
BORDDERLINE SIGNIFICANCE IS DENOTED BY DIFFERENT NUMBER OF STARS AND P-VALUE IS SHOWN. 
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 3.4 Phytosterols in liver 
The liver phytosterol content in the RO fed fish was significantly higher than in the fish fed 
the other feeds at both the intermediate and final sampling (p < 0.003, figure 3.7a and 3.7b). 
There was an observed change in time where the RO fed fish had an increase in liver 
phytosterols from the initial to the final sampling, whilst the rest of the dietary groups had a 
decrease in the phytosterol levels during the same period (see figure 3.8). There was a general 
trend that when the amount of phytosterol in the feed increased, the amount of phytosterols in 
the liver also increased (correlation = 0.77, figure 3.9). Although, this could merely be due to 
the strong influence the RO fed group‟s data exerts on the rest, the trend of increasing 
phytosterol in liver due to increased phytosterol in the feed might just be the case only for 
concentrations as high as in the RO feed.  All the experimental feeds had different 
phytosterol/cholesterol ratios, being: FO: 0.15; OO: 1.51; RO: 2.18; and SO: 1.25. The groups 
fed FO, OO and SO feed had approximately the same ratio of phytosterols : cholesterol in the 
liver at 0.02, the RO fed fish had a ratio at 0.06.  
The composition of phytosterols in the liver did also change during the feeding trial. The 
main phytosterols in the liver before the experiment started were campesterol, at 78 wt% of 
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FIGURE 3.5: CHOLESTEROL CONTENTS IN THE LIVER OF 
ATLANTIC SALMON FED DIFFERENT OILS IN DIET. SEEN IN A 
TIME PERSPECTIVE, T=0 VALUE IS THE SAME FOR EVERY 
GROUP. FO: FISH OIL. OO: OLIVE OIL, RO: RAPESEED OIL, SO: 
SOYBEAN OIL. DATA IS PRESENTED AS MEAN ± SD. 
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FIGURE 3.6: RELATIONSHIP BETWEEN THE 
PHYTOSTEROL AMOUNT IN FEED AND CHOLESTEROL 
IN LIVER, DATA FROM FISH SAMPLED AT 
INTERMEDIATE AND FINAL SAMPLING (T=11 AND 28 
WEEKS, RESPECTIVELY). THE LINEAR MODEL 
PLOTTED EXPLAINS 40% OF THE VARIABILITY IN THE 
DATA (MULTIPLE R-SQUARED = 0.40). THE FISH OIL 
GROUP IS LEFT OUT BECAUSE OF THE HIGH 
CHOLESTEROL CONTENTS IN THE FO FEED 
COMPARED TO THE VO FEEDS, THIS MAKES IT 
POSSIBLE TO SEE THE EFFECT OF ONLY 
PHYTOSTEROLS ON THE CHOLESTEROL LEVELS IN 
THE LIVER. 
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the phytosterols. The percentage of campesterol of total phytosterols did decrease with time 
(figure 3.10a), but it remained the main liver phytosterol in all the dietary groups throughout 
the whole experiment.  The percentage of β-sitosterol of total phytosterols increased at each 
sampling (figure 3.10b), whilst both brassicasterol and sitostanol increased at the intermediate 
sampling and decreased to approximately original levels at the final sampling (figure 3.10c 
and 3.10d). The amount of a sterol in the liver did not always reflect the amount of that 
particular sterol in the feed they were given. The sterols that had the most dramatic difference 
between ratios of „particular phytosterol:total phytosterol’ were campesterol, which occurred 
in ratios up to 5 times higher in the liver than in the feed, and β-sitosterol which was found in 
ratios up to 3 times lower in the liver than in the feed.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.7: PHYTOSTEROL CONTENTS IN LIVER SAMPLED FROM ATLANTIC SALMON FED DIFFERENT OILS IN 
DIET, SAMPLED AFTER A: 11 WEEKS AND B: 28 WEEKS. VALUES PORTRAYED ARE THE STANDARD BOX-AND-
WHISKER PLOT IN R, I.E. MEDIAN, AND FIRST AND THIRD QUARTILE (Q1 AND Q3). WHISKERS ARE MIN. AND 
MAX. VALUES. STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE DENOTED BY DIFFERENT LETTERS. 
 
FIGURE 3.8: PHYTOSTEROL CONTENTS IN THE LIVER OF ATLANTIC 
SALMON FED DIFFERENT OILS IN THEIR FEEDS SEEN IN A TIME 
PERSPECTIVE, T=0 VALUE IS THE SAME FOR EVERY GROUP. FO: FISH 
OIL. OO: OLIVE OIL, RO: RAPESEED OIL, SO: SOYBEAN OIL. 
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FIGURE 3.9: RELATIONSHIP BETWEEN PHYTOSTEROL 
AMOUNT IN FEED AND PHYTOSTEROL IN LIVER OF 
ATLANTIC SALMON FED FEEDS WITH DIFFERENT LIPID 
SOURCES. DATA FROM FISH SAMPLED AT 
INTERMEDIATE AND FINAL SAMPLING (T=11 AND 28 
WEEKS RESPECTIVELY). THE LINEAR MODEL PLOTTED 
EXPLAINS 75% OF THE VARIABILITY IN THE DATA 
(MULTIPLE R-SQUARED = 0.75). THE FISH OIL GROUP IS 
LEFT OUT BECAUSE OF THE HIGH CHOLESTEROL 
CONTENTS IN THE FO FEED COMPARED TO THE VO 
FEEDS, THIS MAKES IT POSSIBLE TO SEE THE EFFECT OF 
ONLY PHYTOSTEROLS ON THE PHYTOSTEROL LEVELS IN 
THE LIVER. 
 
FIGURE 3.10: RELATIVE LIVER STEROL LEVELS DURING THE 28 WEEKS OF FEEDING ATLANTIC SALMON THE 
EXPERIMENTAL DIETS. A: CAMPESTEROL. B: Β-SITOSTEROL, C: SITOSTANOL, D: BRASSICASTEROL. RESULTS 
GIVEN AS WT% OF TOTAL PHYTOSTEROLS ± SD (N=3). 
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3.5 Liver triacylglycerol (TAG) and hepatosomatic index (HSI) 
 
Liver TAG at the final sampling was 
significantly higher in the RO fed fish 
compared to the FO group (p = 0.04), 
and borderline significantly different 
from the SO group (figure 3.11).   
Hepatosomatic index was calculated 
as: (liver weight * 100) / body weight, 
and did not differ significantly 
between the dietary groups with a 
mean value at 1.08 ± 0.14. 
 
 
 
3.5 Sterols in faeces and apparent digestibility  
The faeces samples were analyzed for phytosterol contents and the apparent digestibility 
coefficient (ADC) was calculated for each sterol. The ADC values for the specific 
phytosterols and total phytosterols were very varying and often undetectable, only the ADC 
values for cholesterol were detectable. Because of non-homogeneous variation in the ADC 
cholesterol values, non-parametric tests were performed for these data. The FO fed fish had a 
significantly higher digestibility of cholesterol than the RO fed fish (p = 0.025, t-test- figure 
3.12). 
To look at the relative amounts of phytosterols excreted and compare this between the groups, 
the following calculation was done: amount of specific sterol in faeces/ yttrium in faeces for 
that sample. Comparing the phytosterol content in each diet with the relative amount of 
phytosterols in faeces, it was apparent that the levels of phytosterols in faeces generally 
varied with the levels in the feed given to them (figure 3.13).  
FIGURE 3.11: CONTENTS OF TRIACYLGLYCEROLS (TAG), MG TAG 
PER KG LIVER, IN ATLANTIC SALMON FED DIFFERENT 
EXPERIMENTAL DIETS DURING 28 WEEKS. SHOWN AS MEAN ± SD. 
STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE 
DENOTED BY DIFFERENT LETTERS, BORDERLINE SIGNIFICANCE 
DENOTED BY DIFFERENT NUMBER OF STARS AND P-VALUE IS 
SHOWN (N=3). 
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FIGURE 3.12: APPARENT DIGESTIBILITY COEFFICIENT (ADC) VALUES OF CHOLESTEROL IN ATLANTIC SALMON 
GIVEN DIFFERENT LIPID SOURCES IN THEIR DIET. SHOWN AS MEAN VALUES FOR EACH DIETARY GROUP± SD 
(N=3).  STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE DENOTED BY DIFFERENT LETTERS. 
 
 
  
FO 
 
OO 
 
RO 
 
SO 
Total  
phytosterol 
318.2 1044.2 1872.3 874.3 
Campesterol 60.9 113.1 583 174.3 
β-Sitosterol 143.3 564.4 821.5 439.6 
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FIGURE 3.13: RELATIVE AMOUNTS IN FAECES OF A: TOTAL PHYTOSTEROLS; B: CAMPESTEROL; C: SITOSTEROL (MG 
STEROL KG FAECES-1 / MG YTTRIUM KG FAECES-1) IN ATLANTIC SALMON FED DIFFERENT DIETS. TABLE IS SHOWING 
CONTENTS IN FEED OF PHYTOSTEROLS (MG KG-1). FO: FISH OIL. OO: OLIVE OIL, RO: RAPESEED OIL, SO: SOYBEAN OIL. 
STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE DENOTED BY DIFFERENT LETTERS. VALUES PORTRAYED 
ARE THE STANDARD BOX-AND-WHISKER PLOT IN R, I.E. MEDIAN, AND FIRST AND THIRD QUARTILE (Q1 AND Q3). 
WHISKERS ARE MIN. AND MAX. VALUES. NO SIGNIFICANT DIFFERENCES BETWEEN DIETARY GROUPS. 
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3.6 Plasma and lipoprotein cholesterol, TAG, ALAT and ASAT 
The cholesterol content in plasma and the different lipoprotein fractions did not differ 
significantly between the dietary groups in any of the samplings (table 3.2 and 3.3), although 
when plotting the data there was a trend of higher VLDL cholesterol levels in the OO and RO 
group than in the two other groups at the intermediate sampling (figure 3.14a). The VLDL 
protein was also slightly higher in the RO group (see figure 3.14b), which indicates that this 
dietary group had a higher number of VLDL particles in plasma than the others, whilst the 
OO group merely had an increase of the cholesterol amount in each VLDL particle. No 
significant differences were seen in the HDL protein levels. A change with time was seen in 
the lipoprotein levels of HDL and NLP cholesterol in all the dietary groups. The mean level 
of HDL cholesterol decreased with 53% from the intermediate sampling to the final sampling, 
and a 1.98 times increase was seen in the NLP cholesterol level during the same period (table 
3.2 and 3.3). This change is, however, most likely caused by differences in sampling time 
after last meal at the two samplings (see section 4.3). 
 
TABLE 3.2:  CHOLESTEROL CONTENTS IN PLASMA AND LIPOPROTEIN FRACTIONS IN ATLANTIC SALMON FED 
DIETS WITH DIFFERENT OILS, SAMPLED AT T=11 WEEKS. RESULTS GIVEN AS MG CHOLESTEROL PER 100G 
PLASMA. DATA GIVEN AS MEAN ± SD (N=3). FISH WERE FED 24 HOURS PRIOR TO SAMPLING. 
 Fish oil Olive oil Rapeseed oil Soybean oil 
Plasma  282.8 ± 20.6 304.1 ± 12.4 272.9 ± 19.0 312.6 ± 33.0 
HDL  124.0 ± 11.3 143.8 ± 9.9 126.2 ± 8.1 134.4 ± 13.6 
LDL  27.5 ± 2.5 35.9 ± 8.0 29.1 ± 3.9 34.0 ± 8.0 
VLDL  11.6 ± 1.1 23.2 ± 9.6 15.4 ± 3.1 15.1 ± 4.5 
NLP  53.3 ± 1.2 45.6 ± 4.7 44.6 ± 9.0 57.6 ± 9.3 
 
 
 
 
TABLE 3.3: CHOLESTEROL CONTENTS IN PLASMA AND LIPOPROTEIN FRACTIONS IN ATLANTIC SALMON FED 
DIETS WITH DIFFERENT OILS, SAMPLED AT T=28 WEEKS. RESULTS GIVEN AS MG CHOLESTEROL PER 100G 
PLASMA.  DATA GIVEN AS MEAN ± SD (N=3). FISH WERE FED 48 HOURS PRIOR TO SAMPLING. 
 Fish oil Olive oil Rapeseed oil Soybean oil 
Plasma 290.0 ± 22.8 331.0 ± 16.5 305.1 ± 33.2 324.1 ± 25.1 
HDL 61.9 ± 16 53.7 ± 2.4 64.7 ± 20.9 66.6 ± 14 
LDL  26.0 ± 7.5 34.9 ± 9.8 24.7 ± 3.4 29.8 ± 2.6 
VLDL  8.7 ± 2.7 17.1 ± 4.7 19.3 ± 6.9 11.2 ± 3.0 
NLP  89.0 ± 12.2 126.9 ± 20.7 87.1 ± 12.9 96.0 ± 15.1 
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No significant differences were found between the dietary groups in plasma TAG levels at the 
intermediate sampling, e.g. after 11 weeks of feeding, but after 28 weeks of feeding there 
were some significant differences as shown in table 3.4. The RO fed fish had a higher content 
of TAG in plasma than the other groups at 2.5 ± 0.3 µmol TAG g
-1
 plasma, the FO group had 
the lowest mean value of plasma TAG at 1.6 ± 0.3 µmol TAG g
-1
 plasma
 
(table 3.4). 
Significant differences were also found between the RO and FO groups in the HDL and 
VLDL fractions and between the SO and RO groups in the VLDL fraction of plasma sampled 
28 weeks into the feeding trial. No significant differences between the dietary groups were 
found in the plasma levels of alaninaminotransferase (ALAT) or aspartataminotransferase 
(ASAT), which had means of 0.1 ± 0.1 and 46.2 ± 3.3 UI per 100 g plasma at the initial 
sampling; 1.1 ± 2.4 and 16.3 ± 11.4 UI per 100 g plasma at the intermediate sampling; and 
19.0 ± 17.3 and 68.9 ± 67.1 UI per 100 g plasma at the final sampling, respectively. 
 
 
TABLE 3.4: TRIACYLGLYCEROL (TAG) CONTENTS IN PLASMA AND LIPOPROTEIN FRACTIONS IN ATLANTIC 
SALMON FED DIETS WITH DIFFERENT OILS, SAMPLED AT T=28 WEEKS. RESULTS GIVEN AS µMOL TAG PER GRAM 
PLASMA.  DATA GIVEN AS MEAN ± SD (N=3). STATISTICAL DIFFERENCES BETWEEN DIETARY GROUPS ARE 
DENOTED BY DIFFERENT LETTERS. 
 Fish oil Olive oil Rapeseed oil Soybean oil 
Plasma  1.58b ± 0.27 2.10ab ± 0.14 2.51a ± 0.34 1.74b ± 0.19 
HDL  0.32b ± 0.07 0.40ab ± 0.06 0.52a ± 0.04 0.39ab ± 0.06 
LDL  0.22 ± 0.01 0.29 ± 0.08 0.36 ± 0.18 0.24 ± 0.04 
VLDL  0.44b ± 0.15 0.68ab ± 0.13 0.91a ± 0.14 0.47ab ± 0.17 
NLP 0.43 ± 0.11 0.62 ± 0.16 0.52 ± 0.20 0.44 ± 0.05 
 
A) B) 
FIGURE 3.14: A: VLDL CHOLESTEROL AND B: VLDL PROTEIN IN PLASMA FROM ATLANTIC SALMON FED DIETS 
WITH DIFFERENT OILS, SAMPLED 28 WEEKS INTO THE FEEDING TRIAL. VALUES PORTRAYED ARE THE 
STANDARD BOX-AND-WHISKER PLOT IN R, I.E. MEDIAN, AND FIRST AND THIRD QUARTILE (Q1 AND Q3). 
WHISKERS ARE MIN. AND MAX. VALUES. NO SIGNIFICANT DIFFERENCES BETWEEN DIETARY GROUPS. 
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3.7 Transcription of genes related to the cholesterol metabolism 
A series of genes involved in the biosynthesis, metabolism, uptake and excretion of 
cholesterol and other sterols were selected for performing qPCR on RNA extracted from liver 
and intestine of Atlantic salmon fed different experimental feeds. Some of the genes showing 
changes in expression were the genes involved in the biosynthesis of cholesterol from acetyl-
CoA (a-ACAT2, DHCR7 and MVK), which had a general upregulation of their expression in 
the VO fed fish compared to the FO fed fish (figure 3.15 and 3.16). The upregulation of these 
genes was more pronounced in the intermediate sampling than at the final sampling. At the 
intermediate sampling (figure 3.15), the normalized expression of these three genes was 
between 1.8-3.3 times higher in the VO groups than in the FO group and they were 
significantly upregulated at five occasions (see table 3.5 for relative expressions and p-
values), as opposed to at the final sampling (figure 3.16) when they were between 0.8 - 7.1 
times higher and upregulated only three times. The gene that maintained its high expression is 
a-ACAT2, which had a 7.2 times higher expression in the OO fed fish than in the FO fed fish 
at the final sampling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.15: NORMALIZED EXPRESSION OF GENES IN LIVER FROM ATLANTIC SALMON FED DIFFERENT 
EXPERIMENTAL DIETS FOR 11 WEEKS. FO: FISH OIL. OO: OLIVE OIL, RO: RAPESEED OIL, SO: SOYBEAN OIL. 
STATISTICAL DIFFERENCES BETWEEN DIETARY TREATMENTS ARE DENOTED BY DIFFERENT LETTERS, 
BORDERLINE SIGNIFICANCE IS DENOTED BY DIFFERENT NUMBERS OF STARS AND P-VALUE IS SHOWN. 
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Genes coding for nuclear receptors involved in the regulation of the cholesterol metabolism 
(LXR and SREBP2) did show some changes in expression during the dietary trial. At the 
intermediate sampling the expression of LXR remained very stable in all the dietary groups, 
whilst the SREBP2 expression was found to be 2.1 and 1.9 times higher and borderline 
significantly different in the RO and SO groups compared to the FO group, respectively (table 
3.5 and figure 3.15). At the final sampling the differences between the VO and FO group in 
the expression of these two genes had increased. The LXR was now significantly 
downregulated in the RO fed fish compared to the FO group (p=0.028) and SREBP2 was 
highly upregulated in the VO groups (from 2.2 – 4.3 times higher in VO than FO, figure 
3.16). 
Expression of genes coding for proteins transporting sterols between the intestinal lumen and 
the enterocytes, ABCG5 and NPC1L1, had not been affected by the diets after 11 weeks of 
being fed the experimental diet. At the final sampling, T=28 weeks, there had been an 
upregulation in the SO group of the gene coding for the protein NPC1L1 (p=0.02, table 3.6), 
which is a protein that transports sterols from the lumen to the enterocytes. There was also a 
tendency of the OO group having this gene higher expressed, and for RO having it lower 
expressed at T=28 weeks. 
The expression of genes coding for the different apolipoproteins were expressed quite stable 
through the whole feeding trial. The only exception from this was ApoA1, the apolipoprotein 
commonly found in chylomicrons and HDL particles, which was expressed 1.66 times higher 
in the OO fed fish compared to the FO fed fish in liver from the final sampling (p=0.084). 
FIGURE 3.16: NORMALIZED EXPRESSION OF GENES IN LIVER FROM ATLANTIC SALMON FED DIFFERENT 
EXPERIMENTAL DIETS FOR 28 WEEKS. FO: FISH OIL. OO: OLIVE OIL, RO: RAPESEED OIL, SO: SOYBEAN OIL. 
STATISTICAL DIFFERENCES BETWEEN DIETARY TREATMENTS ARE DENOTED BY DIFFERENT LETTERS. 
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The LDL-receptor, involved in the lipoprotein metabolism, was not fluctuating in its 
expression (table 3.5).  
Significant differences were seen in the expression of CYP7A1, rate-determining enzyme in 
the conversion of cholesterol to bile salts. CYP7A1 was expressed 3.1 times higher in the RO 
group than in the FO group at the intermediate, but strongly downregulated in the same 
dietary group at the final sampling. The SO group had a development in expression of 
CYP7A1 contrary of RO, being low at the intermediate sampling and high at the final 
sampling (table 3.5 and figure 3.15 and 3.16).  
 
TABLE 3.5: RELATIVE EXPRESSION OF GENES INVOLVED WITH CHOLESTEROL SYNTHESIS, LIPOPROTEINS AND 
CHOLESTEROL EFFLUX IN LIVER TISSUE FROM ATLANTIC SALMON FED DIFFERENT OILS IN THEIR FEED. TISSUE 
FROM THE INTERMEDIATE AND FINAL SAMPLING (T=11 AND 28 WEEKS, RESPECTIVELY). THE NUMBERS 
INDICATE FOLD CHANGE RELATIVE TO THE FISH OIL GROUP.  THE GENES WHICH HAD A SIGNIFICANTLY 
DIFFERENT EXPRESSION IN VO FED FISH COMPARED TO FO FED FISH ARE INDICATED IN BOLD (P-VALUES <0.05, 
NESTED ANOVA AND TUKEY HSD). 
  Gene Olive oil Rapeseed oil Soybean oil 
   expression p-value expression p-value expression p-value 
  ACAT2 2.739 0.014 3.286 <0.001 2.122 0.210 
 Chol. DHCR7 2.298 0.012 3.108 <0.001 1.755 0.282 
 synth. HMGR 0.866 0.973 1.379 0.617 1.144 0.967 
  MVK 1.915 0.152 2.360 0.010 2.032 0.083 
T= 11   SREBP2 1.392 0.143 2.137 0.059 1.905 0.052 
weeks  ApoA1 0.912 0.986 1.479 0.252 1.152 0.936 
 Lipo. ApoB100 0.922 0.987 1.331 0.498 0.893 0.969 
 prot. Apo C2 0.884 0.982 1.381 0.601 0.922 0.994 
  LDLR 0.864 0.881 0.972 0.999 0.987 1.000 
 Chol. CYP7A1 0.943 0.906 3.098 0.025 0.449 0.006 
 efflux LXR 0.873 0.968 1.205 0.883 1.072 0.994 
  ACAT2 7.139 0.017 3.125 0.001 1.557 0.067 
 Chol. DHCR7 2.404 0.009 1.152 0.986 1.037 0.999 
 synth. HMGR 1.268 0.713 1.091 0.984 1.140 0.945 
  MVK 1.389 0.308 0.846 0.915 0.977 0.999 
T= 28   SREBP2 4.241 0.034 2.220 0.060 2.637 0.020 
weeks  ApoA1 1.663 0.084 1.357 0.580 1.309 0.687 
 Lipo. ApoB100 1.989 0.305 0.800 0.990 1.574 0.813 
 prot. Apo C2 1.284 0.445 1.038 0.997 1.250 0.559 
  LDLR 1.386 0.787 0.957 0.999 1.468 0.671 
 Chol. CYP7A1 1.106 0.806 0.313 0.087 2.029 0.176 
 efflux LXR 0.856 0.363 0.755 0.028 1.010 0.999 
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TABLE 3.6: EXPRESSION OF GENES EXPRESSING INTESTINAL STEROL TRANSPORTERS IN INTESTINE OF 
ATLANTIC SALMON FED DIFFERENT OILS IN THEIR FEED. TISSUE FROM THE INTERMEDIATE AND FINAL 
SAMPLING (T=11 AND 28 WEEKS, RESPECTIVELY). THE NUMBERS INDICATE FOLD CHANGE RELATIVE TO THE 
FISH OIL GROUP. THE GENES WHICH HAD A SIGNIFICANTLY DIFFERENT EXPRESSION IN VO FED FISH COMPARED 
TO FO FED FISH ARE INDICATED IN BOLD (P-VALUES <0.05, NESTED ANOVA AND TUKEY HSD).  
 
 
 
 
 Gene Olive oil Rapeseed oil Soybean oil 
  expression p-value expression p-value expression p-value 
T=11  ABCG5 1.068 0.824 0.754 0.426 1.058 0.849 
weeks NPC1L1 1.178 0.664 1.423 0.314 1.171 0.675 
T=28  ABCG5 0.812 0.294 0.704 0.115 0.976 0.887 
weeks NPC1L1 1.480 0.131 0.770 0.443 1.804 0.022 
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4. Discussion 
4.1 Effect of vegetable oil and plant protein on growth and feed intake 
of Atlantic salmon 
The fish fed soybean oil (SO) showed a tendency of lower final weight and were borderline 
significantly shorter (p = 0.066) compared to the fish oil (FO) fed group. In addition, the SO 
fed fish had a lower specific growth rate (SGR) than the fish fed olive oil (OO) and rapeseed 
oil (RO). Feeding trials where plant oils have replaced marine oils in the feed, but where the 
protein portion was fishmeal, have mostly shown no significant differences in final weight or 
growth between the FO and vegetable oil (VO) fed fish (Leaver et al., 2008; Miller et al., 
2008; Torstensen et al., 2005), although Torstensen et al. (2005) observed reduced growth in 
the FO fish during the winter season. This reduced growth was thought to be due to decreased 
digestibility of saturated fatty acids (SFA), abundant in FO, at low temperatures.  
A lower final weight has been reported in fish given high replacement of both protein and 
lipids (80% PP and 70% VO) (Torstensen et al., 2008). This lower weight was explained by 
significantly decreased feed intake during the first period, which is similar to what we 
observed in our results where the SO fish had significantly lower feed intake compared to FO.  
The higher feed conversion ratio (FCR) in the VO fed groups than in the FO fed group in our 
dietary trial is also in accordance to what was reported by Torstensen et al. (2008).  
In feed preference studies where voluntary feed intake has been investigated, VOs have been 
reported as less accepted by the Atlantic salmon resulting in lower feed intake and 
subsequently lower growth rate (Geurden et al., 2005; 2007). SGR was affected by the oil 
source and it appears that, in the case of high inclusion of plant protein in the diet of Atlantic 
salmon, the type of lipid utilized does indeed influence the growth of the fish. The FO and 
RO diets gave high final weights, but FO fed fish had a less efficient feed utilization (higher 
FCR), hence the FO fed fish had to eat more to obtain the same final weight. The OO fed fish 
had intermediate growth and feed intake compared to the other dietary groups. SO seems to 
be the oil less suited for replacing FO in feed for Atlantic salmon, in the sense that it gave 
slightly lower final weight, probably caused by the low feed intake by this dietary group. The 
higher digestibility of the VO diets compared to the FO diet (unpublished data), probably 
balance this lowered feed intake, making it the reason that the decrease in growth is not as 
dramatical as the lowered feed intake would suggest. Based on current and previous studies, it 
seems that replacement of FO with VO in diet does not severely affect the growth and feed 
intake of Atlantic salmon. 
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4.2 Absorption of sterols 
Feeding Atlantic salmon with OO and SO diets during 28 weeks led to an upregulation of the 
expression of NPC1L1 compared to the FO fish (p = 0.022 and p = 0.131, respectively). The 
RO fed fish had a slightly lowered expression of NPC1L1 in the intestine compared to the FO 
group. Clinical trials with mildly hypercholesterolemic and sitosterolemic humans have given 
indications of NPC1L1 being important for the absorption of both cholesterol and 
phytosterols (Garcia-Calvo et al., 2005; Salen et al., 2004; Sudhop et al., 2002). The 
expression of NPC1L1 mRNA has been shown to correlate with the amount of NPC1L1 
protein in the intestine of rat, mouse and human, and to be strongly correlated with the 
absorption of sterols as mice deficient in NPC1L1 reduce their cholesterol absorption by 
~70% (Altmann et al., 2004). Assuming that Atlantic salmon NPC1L1 has a translation and 
subsequent function as the mammalian NPC1L1, the sterol absorbing ability was higher in the 
OO and SO fed fish than in the FO and RO fed fish. It has, however, been indicated that 
NPC1L1 resides intracellularly and moves to the cell membrane in case of cellular cholesterol 
depletion (Yu et al., 2006); if this is the case also in Atlantic salmon is not known.  However, 
if the latter is true in Atlantic salmon, the expression of NPC1L1 in the intestine is not 
necessarily reflecting the ability to absorb sterols at a given moment, but may rather be 
expressed to build and intracellular NPC1L1 pool.  
The NPC1L1 protein has a sterol sensing domain (Altmann et al., 2004), and its activity can 
thus be affected by sterols. Accordingly, Jesch et al. (2009) showed that the presence of β-
sitosterol and cholesterol, but not stigmasterol, lowered the expression of NPC1L1 in a 
human enterocytic cell-line. Our results are in line with this, as the SO and OO feeds were the 
ones with the lowest dietary levels of β-sitosterol and cholesterol and the highest expression 
of NPC1L1. It therefore seems that the β-sitosterol and cholesterol contents in the SO and OO 
diets were below the levels needed to lower the expression of the NPC1L1 transporter, and 
consequently giving higher levels of NPC1L1 in these groups due to no suppression of 
expression. The level of β-sitosterol in the RO diet appears to have been high enough to 
suppress the expression of NPC1L1 in this dietary group, giving this group a lower 
expression of NPC1L1 than the other dietary groups. The FO fed fish also had a lower 
expression of NPC1L1 than the OO and SO fed fish, which could be due to the high 
cholesterol levels in the FO feed. The fact that the RO fed fish had an even lower expression 
of NPC1L1 than the fish fed FO indicate that phytosterols may have a stronger inhibiting 
effect on this receptor than cholesterol in Atlantic salmon. It appears that the FO diet 
contained sufficient cholesterol and the RO diet sufficient β-sitosterol to lower the expression 
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of NPC1L1 in Atlantic salmon, but that the OO and SO diet had too low levels of both these 
sterols to have an effect on NPC1L1 expression. 
Fatty acids are also reported to affect the expression of NPC1L1, with DHA  lowering the 
expression of NPC1L1 in hamster proximal intestine compared to oleic acid (Mathur et al., 
2007). In accordance, EPA and DHA have shown to decrease the expression of NPC1L1 in 
enterocytic membranes in vitro (Alvaro et al., 2010). In contrast, varying levels of saturated 
or monounsaturated fatty acids did not alter the expression of NPC1L1 (Alvaro et al., 2010). 
Considering dietary fatty acid composition (table 2.2), this could explain the expression 
pattern of NPC1L1 in the FO, OO and SO fed fish after 28 weeks, but the low expression of 
NPC1L1 in the RO fed fish after 28 weeks of feeding cannot be explained directly by the 
amounts of EPA and DHA in the feed. It could be that HUFA lowers the expression of 
NPC1L1 in the FO fed fish, however phytosterols seem more important for the control of the 
NPC1L1 expression in the VO fed fish.  
Some indications of how well the sterols are absorbed compared to each other, can be found 
by comparing the sterol ratios in the diet to the ones it the liver. The ratio of phytosterol : 
cholesterol was higher in the feed than in the liver for all the dietary groups, indicating a less 
efficient absorption of phytosterols than of cholesterol. The ratio of campesterol : total sterols 
was higher in the liver of all feed groups than in the feed, whilst β-sitosterol was found in 
lower proportions in the liver than in the feed, meaning that campesterol was accumulated in 
the liver more than β-sitosterol. These results are in line with earlier research on salmon parr, 
which showed that C29 phytosterols, as β-sitosterol, have reduced digestibility compared to 
C28 phytosterols, as campesterol,  and were consequently less accumulated in liver and white 
muscle (Miller et al., 2008). This difference in absorption and hepatic retention could be 
connected to the suspected existence of differences in efficiency of the various sterol ACATs 
(Hamada et al., 2007; Sabeva et al., 2009). The absorption of particular sterols in Atlantic 
salmon thus seems to be selective, absorbing campesterol more efficiently than β-sitosterol.  
The apparent digestibility coefficient (ADC) was undetectable for nearly all the sterols, 
except for the cholesterol ADC values which were significantly lower in the RO fed fish than 
in the FO fed fish. These results are in accordance to what has been observed for humans, as a 
naturally high-phytosterol diet give an increase in the faecal excretion of cholesterol (Lin et 
al., 2010). Summarizing the results on sterol absorption, RO fed fish had a lower expression 
of the sterol absorbing NPC1L1 and an increased intestinal efflux of sterols. It therefore 
seems that the effect of a high-phytosterol diet on Atlantic salmon is similar to the effect 
observed in humans, consisting in an increased efflux of cholesterol caused by a decreased 
intestinal absorption of the same sterol. 
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4.3 Effect of vegetable oils and plant protein on plasma cholesterol 
and plasma TAG  
There were no significant changes between the dietary groups in the cholesterol of plasma 
and lipoprotein fractions, revealing that a plant based feed, formulated as in this experiment, 
did not severely affect the plasma cholesterol. In humans, phytosterol and phytostanols given 
in dosages between 0.8 - 4.0 g daily give reductions of LDL-cholesterol between 10 - 15% 
(Katan et al., 2003). The intake of sterols per VO fish through the whole period ranged from 
2.6 g (SO) to 6.1 g (RO). This translates into approximately 13 mg (SO) to 31 mg (RO) of 
phytosterols per day, which, when taking into account the normal weight of a human (~70 
kg), compared to the weight of the salmon (~4 kg at slaughter), is a level that could be 
comparable to what would lower the LDL-cholesterol in a human.  
The plasma cholesterol levels in our experiment started at 6.15 mmol L
-1
 (initial sampling, 
April) and had increased to 8.16 mmol L
-1
 at the final sampling in October. This can be 
compared with the normal plasma cholesterol ranges of Atlantic salmon (1.4 - 4.2 kg) fed 
traditional feed with fish oil and fish meal, found to vary between 9.3 mmol L
-1
 (May) and 
12.8 mmol L
-1
 (December) (Sandnes et al., 1988), however current plasma cholesterol was 
consistently lower compared to this. The feed given to the fish investigated by Sandnes et al. 
(1988) was not analyzed for cholesterol, but the traditional aquaculture diets usually have a 
cholesterol contents at about 3000-4000 mg kg feed
-1
 (Torstensen et al., in prep.). This is 
somewhat higher than in our experimental diets, where the FO feed contained 2111 and 2576 
mg of cholesterol per kg feed in batch 1 and batch 2, respectively. In dietary trials where both 
traditional feed with fish oil and fish meal as well as diets with 80% PP and 70% VO 
(80PP70VO) replacement are given to Atlantic salmon, lower plasma cholesterol has been 
observed in the fish given the high replacement feed (Torstsensen et al., in prep.). Based on 
the fact that all the dietary groups from this feeding trial had lower plasma cholesterol than 
traditionally fed Atlantic salmon and that no difference were seen between the dietary groups, 
the earlier observed effects of plant ingredients in feed are probably due to the high  and equal 
plant protein inclusion in all experimental diets.  
The RO fed fish had a significantly higher plasma TAG level than the SO and FO fed fish, 
which is similar to the results seen by Torstensen et al. (2011) where a 80PP70VO-diet 
resulted in increased plasma TAG in adult Atlantic salmon. It has been shown that both EPA 
and DHA lower plasma TAG (Frøyland et al., 1996), which explains the low levels of plasma 
TAG in the FO fed fish but not in the SO and OO fed fish. A trend of higher VLDL protein 
and VLDL cholesterol in the RO group, supports the theory proposed by Torstensen et al. 
(2011), where they suggest that the increased plasma TAG levels is a results of increased 
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secretion of TAG-rich VLDL from the liver. An increased expression of ApoB100 has also 
been seen as a result of the 80PP70VO diet (Torstensen et al., 2011); this was however not 
supported by the current data. The high TAG levels in the liver of the RO fed fish, agrees 
with the increased levels of VLDL and transport of TAG to the tissues. At the same time as 
forward sterol and lipid transport by VLDL is increased it could be that also the reverse 
cholesterol transport is affected by plant derived feed, as suggested by Cruz-Garcia et al. 
(2010). This hypothesis was made due to the changes seen in the expression of LXR, which 
regulates ABCA1; the latter one having an essential role in the formation of HDL (Fielding 
and Fielding, 2008). 
A pronounced change in the ratio between NLP and HDL cholesterol was observed from the 
intermediate sampling to the final sampling. These changes are, however, most likely caused 
by the different feeding statuses in the two samplings, the fish from the final sampling having 
had 48h since their last meal, to ensure that the fish were in a post-absorptive phase when 
sampled, and the ones from the intermediate sampling only 24h. This could lead to the fish 
sampled at the final sampling having more heavy HDL particles, e.g. containing less fat and 
more protein, which means that they could have been centrifuged out in the NLP phase and 
with this causing the increased size of the NLP fraction.  The plasma cholesterol levels from 
the two samplings can thus not be directly compared. 
Plasma cholesterol was not affected by dietary phytosterols or EPA and DHA, although a 
tendency of higher VLDL cholesterol and protein was seen in the RO group. In humans, 
sitostanol lowers the circulating cholesterol if both cholesterol and phytosterol is above a 
threshold level (Jones et al., 1997). How Atlantic salmon would react to high levels of both 
phytosterols and cholesterol is not known and was not included in our experimental design. 
However, it seems that when the cholesterol level in their diet is between 759 - 2576 mg per 
kg feed, Atlantic salmon have sufficient mechanisms for regulating their plasma cholesterol. 
4.4 Effect of vegetable oils and plant proteins on the sterol metabolism 
Cholesterol is produced endogenously in the tissues or taken up through the enterocytes, 
whilst phytosterols cannot be synthesized in animals and can only be accumulated by 
ingesting plant material. When sterols are taken up from the intestine, they are transported by 
chylomicrons to the blood where they are transported further to the tissues for either 
assimilation into cell membranes or brought to the liver for transformation into bile acids 
(Altmann et al., 2004; Liscum, 2008). In our results there was a clear trend of increasing 
expression of genes involved in the biosynthesis of cholesterol in liver tissue (SREBP2, 
MVK, DHCR7, and a-ACAT2) of the Atlantic salmon. This is in accordance with Leaver et 
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al. (2008), who showed that VO fed Atlantic salmon upregulated the expression of SREBP2, 
MVK and other genes involved in cholesterol biosynthesis compared to FO fed fish. The fact 
that the expression of HMGR was not affected in the VO fed fish, also supports the findings 
by Leaver et al. (2008), verifying that cholesterol is not a key regulator of salmon-HMGR as 
it is of mammalian-HMGR (Horton et al., 1998; Ravid et al., 2000; Roitelman and Simoni, 
1992). An increase of genes in the cholesterol biosynthetic pathway suggests that there is a 
higher biosynthesis of cholesterol in the VO fed fish than in the FO fed fish. This is in line 
with mammalian findings, which show that a decreased cholesterol absorption caused by 
phytosterol lead to increased hepatic cholesterol synthesis (Moghadasian et al., 1999; Shefer 
et al., 1973). This could indicate an increased need for endogenous production of cholesterol 
in the VO fed fish possibly caused by cholesterol depletion. Phytosterols can exert an effect 
on the cholesterol metabolism through the activity of acetyl-CoA carboxylase and malic 
enzyme if the ratio of phytosterol : cholesterol is larger than 1 (Laraki et al., 1993). The ratio 
of phytosterol : cholesterol in our experimental VO diets ranged from 1.19 in the SO diet to 
2.18 in the RO diet, indicating that the changes we see in the expression of genes involved in 
cholesterol biosynthesis could, in fact, be due to dietary phytosterols. 
Special importance is given to the observed upregulation of SREBP2, nuclear receptor 
activated by low levels of cholesterol in the cytosolic compartment of cells (Gong et al., 
2006), which activates genes involved in cholesterol biosynthesis and uptake of sterols 
(Espenshade and Hughes, 2007; Goldstein et al., 2006; Horton et al., 2002). The stable 
upregulation of SREBP2 in all the VO groups compared to FO, could imply that the liver 
cells of Atlantic salmon fed VO diets are in a state of low or deficient cholesterol. Another 
possibility is that the phytosterols, directly or indirectly, manipulate the expression of 
SREBP2 in some way. In mice it has been shown that an increased expression of SREBPs 
achieved by genetic techniques, is joined by an increase in hepatic synthesis of cholesterol 
and fatty acids (Horton et al., 1998; Zheng et al., 2005) and can give an enlarged or fatty liver 
(Shimano et al., 1996). In spite of high transcription of SREBP2 in several of the dietary 
groups compared to FO, the hepatosomatic index (HSI) did not differ between them. There 
were, however, higher liver TAG levels in the RO fed group than in the other dietary groups. 
It thus appears that one of the results of feeding Atlantic salmon with high phytosterol/low 
cholesterol feed is an increase in the endogenous synthesis of cholesterol and perhaps also 
fatty acids, triggered by SREBP2 and possibly caused by cholesterol depletion in the 
hepatocytes. 
The synthesis of cholesterol is an energy demanding process, so the observed increase in 
expression of genes in the cholesterol biosynthetic pathway in the VO fed groups, could 
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imply an increased energy-demand of the cells of the VO fish. Leaver et al. (2008) reported 
an upregulation of several genes involved in NADPH producing systems and HUFA 
biosynthesis in Atlantic salmon smolt fed VO diets. Based on our data and the observed 
changes by Leaver et al. (2008), this could mean that an increased amount of energy is 
required for the cholesterol and HUFA synthesis and that this energy is spent on the expense 
of other energy-demanding processes. If the energy is administered in a similar way in 
Atlantic salmon as in humans, these energy-demanding processes would, in the case of 
energy depletion in the cell, be inhibited by a sensor of energy status cellular called AMP-
Activated Protein Kinase (AMPK). The activity of AMPK makes sure that catabolic 
processes generating ATP are prioritized over anabolic processes that demand energy and that 
are not essential for the short-term survival of a cell (Hardie et al., 2003). Which processes 
that are prioritized over others in Atlantic salmon is not known. Since cholesterol synthesis is 
observed to be higher in the VO fed salmon, it seems as if the fish are able to handle the 
increased energy-demand these diets impose without compromising growth, possibly due to 
the high dietary energy content.  
4.5 Accumulation of sterols in liver of Atlantic salmon 
Liver cholesterol content in increased in all the dietary groups from the initial to the final 
sampling. Interestingly, in spite of the FO group being the dietary group with the highest 
levels of dietary cholesterol, the FO fed fish was the dietary group with the lowest liver 
cholesterol levels after 28 weeks of feeding. The same tendencies, where the FO group 
increased the least in liver cholesterol and the VO groups more, is also reported for Atlantic 
salmon smolt (Miller et al., 2008). Based on this comparison of results, it looks as if the same 
mechanisms for accumulating cholesterol in the liver are valid for adult Atlantic salmon as for 
juvenile fish of the same species.  
The interesting development in the liver cholesterol of the RO fed fish, which decreased from 
the initial to the intermediate sampling and increased to the levels of the other groups at the 
final sampling, is presumably connected with the phytosterol levels. This presumption is 
based on the negative correlation between the phytosterol contents in feed and the cholesterol 
in the liver, implying that the more phytosterol a fish ingests, the less cholesterol it will 
accumulate in its liver. This is, however, in contrast to what one would expect based on the 
discussion in the former passage. When looking closer at the data, it is quite clear that this 
correlation can be showing skewed results. The RO fed fish is the only group with very high 
phytosterol levels, and it therefore becomes the sole dietary group giving the slope of the line 
representing the linear relationship between the phytosterol in feed and cholesterol in liver 
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(figure 3.6). Because of this, no conclusions will be based on the correlation between feed and 
liver phytosterol. 
Decreased levels of liver phytosterols from the initial to the final sampling were observed in 
all the groups except for in the RO fed fish, which had an increase in liver phytosterols during 
the same period. A commercial feed containing rapeseed oil was used prior to the dietary 
trial, and was most likely the reason why all the fish had high levels of liver phytosterol at the 
start of the dietary trial and a subsequent decrease in phytosterol levels in the same organ. The 
RO feed was the one with the highest content of phytosterols, and since this feed was the only 
one giving accumulation of phytosterols in the liver, all though OO and SO diets also 
contained phytosterols, it could be that the dietary phytosterol has to reach a threshold before 
it is absorbed and accumulated in Atlantic salmon liver. Such a threshold could be connected 
with the phytosterol : cholesterol ratio in the feed or with the phytosterol concentrations in the 
intestine at the moment of absorption. The higher phytosterol : cholesterol ratio in the liver of 
the RO fed fish compared to in the other dietary groups indicate that this threshold limit in the 
phytosterol : cholesterol ratio would lie between 1.42 (ratio in the OO feed) and 2.18 (ratio in 
the RO feed). Since the RO feed was also the one with the highest concentrations of 
phytosterols, a threshold in the amount of total or specific phytosterols present in the 
intestinal lumen after a meal may be determining phytosterol uptake. 
The sterol levels in liver was  positively correlated to the TAG levels in this organ, which 
maybe be due to sterols being lipid soluble and a tissue with a higher fat content thus being 
able to store more phytosterols (Miller et al., 2008). In our experiment, the RO fed fish had a 
significantly higher liver TAG level than the fish fed FO. A connection between a VO diet 
and increased liver lipid in Atlantic salmon was established in Atlantic salmon fed a VO 
blend of rapeseed oil, palm oil and linseed oil during 22 months (Jordal et al., 2007), and 
confirmed by Torstensen et al. (2011) when both dietary FO and fishmeal were replaced by 
plant raw material. Miller et al. (2008) reported that liver lipid levels were significantly higher 
in salmon smolt fed canola oil in their diet compared to salmon smolt fed diets with fish oil 
during 9 weeks, a change that was accompanied by an increase of liver phytosterols in this 
dietary group.  
TAG synthesis in liver is shown to be upregulated by oleic acid and suppressed by EPA 
(Berge et al., 1999; Ranheim et al., 1994) and increased expression of SREBP1-a and -c are 
associated with FA synthesis (Horton et al., 2002) and increased liver lipids (Shimomura et 
al., 1998). This shows that EPA possibly lowers the expression of SREBP1, leading to lower 
FA synthesis. The two isomers of SREBP known in Atlantic salmon respond differently to 
the exposure to EPA and DHA; decreasing the expression of SREBP1 and increasing the 
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expression of SREBP2 in macrophage cell lines (Minghetti et al., 2011). Since both RO and 
SO diets are low in HUFA, we could explain parts of the slightly elevated TAG levels in 
these two groups by the FA composition in feed. The high liver TAG found in the RO group, 
could be also be partially explained by the lack of EPA and DHA in the RO diet, but could, in 
addition, be caused by a cholesterol deficit that activates both SREBPs and thus also FA 
synthesis (Horton et al., 2002). It thus seems that a high phytosterol-low cholesterol diet like 
the RO feed reduces cholesterol uptake, which leads to an upregulation of SREBPs triggered 
by a cholesterol deficit. This upregulation of SREBPs is thought to result in an increased 
synthesis of cholesterol and fatty acids in liver and, consequently, an accumulation of 
phytosterols in this organ (figure 4.1). 
FIGURE 4.1: HYPOTHESIZED EFFECT OF A HIGH PHYTOSTEROL – LOW CHOLESTEROL DIET, LIKE THE RO DIET IN 
THIS EXPERIMENT, ON THE STEROL AND LIPID METABOLISM 
4.6 Efflux of sterols in Atlantic salmon 
LXR, a nuclear receptor important for controlling the homeostasis of cholesterol, was 
expressed in a similar manner in the liver of all the dietary groups during the feeding trial, but 
with a significantly lowered expression in the RO fed fish compared to the FO fed fish at the 
final sampling. LXR controls many genes related to the efflux of cholesterol, amongst them 
CYP7A1, and has been shown to be upregulated by β-sitosterol and campesterol in intestinal 
caco 2 cells (Plat et al., 2005) and by cholesterol in Atlantic salmon HSK-1 cell lines 
(Minghetti et al., 2011). Lowered levels of LXR have been reported in Atlantic salmon fed 
diets with a VO blend (Cruz-Garcia, 2010). The downregulation of LXR in the liver of RO 
fed fish after 28 weeks of feeding, is the contrary of what we would expect based on the 
mentioned results in human cell lines (Plat et al., 2005), since the RO feed had high levels of 
both β-sitosterol and campesterol. Current results are, however, in line with the results in 
Atlantic salmon (Minghetti et al., 2011; Cruz-Garcia, 2010). The effect of phytosterols on 
LXR expression thus seems to be quite different in Atlantic salmon liver than in human 
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enterocytes, although it could be that the modulating effect of phytosterols on the efflux of 
sterols only functions in the case of a high cholesterol diet. 
The lowered expression of both LXR and CYP7A1 in the RO fed fish at the final sampling, 
indicates a low sterol efflux in this dietary group compared to the others. The situation was 
different at the intermediate sampling, where LXR expression in the RO fed fish was slightly 
upregulated compared to FO fed fish and CYP7A1 was highly upregulated, both indicating a 
high sterol efflux through bile acid synthesis. Increased bile production (De Castro-Orós et 
al., 2011; Moghadasian et al., 1999) and increased LXR expression (Plat et al., 2005) are 
known reactions to high levels of phytosterols in humans, supporting current findings in 
Atlantic salmon. Concordantly, a dramatical increase in LXR expression was reported in 
Atlantic salmon macrophage cell lines when exposed to surplus of cholesterol (Minghetti et 
al., 2011). At 11 weeks, the same time as the expression of LXR and CYP7A1 in the RO fed 
group was high, the cholesterol levels in the liver of this dietary group was the lowest, 
possibly due to a high efflux of cholesterol as bile acids, mediated by LXR. At the final 
sampling the liver cholesterol of the RO fed fish had increased up to the level of the other 
groups and LXR and CYP7A1 levels had decreased their expression. This indicates a lowered 
bile acid synthesis during this period between the samplings, accompanied by accumulation 
of cholesterol in liver tissue. An inverse relation between the hepatic cholesterol levels and 
the expression of LXR and CYP7A1 thus seems to exist. Based on this, it appears that the 
cholesterol levels in the liver are more affected by cholesterol synthesis and excretion than by 
dietary cholesterol. And as LXR is shown to increase its expression in Atlantic salmon as a 
response to cholesterol (Minghetti et al., 2011), it could be that LXR functions as a 
cholesterol sensor, activating cholesterol efflux when cholesterol levels in the tissues exceed a 
certain level (figure 4.2). 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.2: HYPOTHESIZED 
MECHANISMS OF CHOLESTEROL 
REGULATION BY LXR. ILLUSTRATED 
AS A PENDULUM SWINGING 
BETWEEN CHOLESTEROL 
SYNTHESIS AND EXCRETION 
ACCORDING TO TISSUE LEVELS OF 
CHOLESTEROL. 
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While the liver cholesterol levels varied in the RO fed fish, the amount of phytosterols in the 
liver of the same dietary group was quite stable throughout the dietary trial, indicating that the 
absorption of phytosterols was unchanged. The decrease in expression of LXR from the 
intermediate to the final sampling in the RO group could have been triggered by the low 
levels of liver cholesterol seen in the fish from this group at the intermediate sampling. It 
therefore appears that a cholesterol deficit will override the upregulating effect phytosterols 
might have on LXR. Alternatively, the regulation of LXR by phytosterols is different in 
Atlantic salmon compared to in mice and human or only functions in the case of excess 
dietary cholesterol. 
The ABCG5/8 and ABCA1 are involved in hepatobiliary transport of cholesterol in humans, 
and ABCG5/8 is shown to be crucial for the removal of cholesterol from the body through the 
intestine (Sabeva et al., 2009). No significant change in expression of ABCG5 was seen in the 
intestine of the Atlantic salmon from this feeding trial. In wildtype mice, however, exposure 
to high concentrations of cholesterol and plant stanols increased the expression of ABCA1 in 
liver and intestine (Plat and Mensink, 2002). It has been shown that the ABCG5/8 and 
ABCA1 proteins are under control of the LXR pathway, which means that they are activated 
by high tissue cholesterol concentrations (Plat and Mensink, 2005; Yu et al., 2003). The 
unfluctuating expression of ABCG5 in the intestinal samples from this feeding experiment, 
indicate that the sterol concentrations in the experimental feeds have been too low for an 
upregulation of ABCG5 to occur.  
4.7 Conclusions 
A replacement of marine raw materials in Atlantic salmon diet with 70% plant protein and 
80% vegetable oils, significantly affected the cholesterol and lipid metabolism.  
The sterol balance was specially affected in the RO fed fish, as they showed tendencies of 
higher VLDL protein and cholesterol, as well as significantly higher plasma TAG. In 
addition, the liver of the RO fed fish had high TAG levels and an accumulation of 
phytosterols, something that was not seen in the other VO or FO fed fish. Based on the 
expression of the transporter protein NPC1L1, the uptake of cholesterol in intestine could be 
lower in the FO and RO fed groups compared to the OO and SO fed groups, possibly because 
of a depression of the receptor‟s expression by cholesterol and β-sitosterol in the FO and RO 
fed fish, respectively. This decreased absorption through NPC1L1 combined with low dietary 
cholesterol in the RO fed fish is suspected to cause a cholesterol deficit. The increased TAG 
content in the liver of the RO fed fish is suggested to be caused by increased expression 
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SREBPs, which are activated by low levels of cholesterol in tissue and trigger the endogenous 
synthesis of cholesterol and fatty acids. 
The plasma cholesterol and lipoprotein cholesterol levels were stable in all the dietary groups 
throughout the dietary trial, demonstrating that this parameter is closely controlled by the 
sterol metabolism of Atlantic salmon. Based on the lack of differences in the current plasma 
cholesterol and differences between dietary groups in other feeding trials (Torstensen et al., in 
prep.), it is probable that it is the plant protein and not the vegetable oil that causes changes in 
plasma and lipoprotein cholesterol.  
Since no effects of the VO diets was seen on plasma and lipoprotein cholesterol, used as 
biomarkers for CVDs in humans, no change in cardiovascular health is expected in VO and 
PP fed fish. 
Different phytosterols were absorbed differently, campesterol being absorbed and stored in 
liver to a higher extent than β-sitosterol.  
The increased expression of SREBP2 in liver of all the VO fed groups could be an indication 
of low cholesterol in the hepatocytes, and is hypothesized to be the trigger of the increased 
expression of genes involved in cholesterol synthesis.  
Liver cholesterol levels varied, and there was a relationship between increased expression of 
genes involved in bile acid synthesis and decreased levels of cholesterol in this organ, and 
vice versa. Liver cholesterol levels increased more with time in the VO fed fish than in the 
FO fed fish, in spite of the FO diets containing more cholesterol.  
Based on the fluctuating expression of genes involved in the production of bile acid, the 
varying liver cholesterol and the stable levels of plasma cholesterol, Atlantic salmon seems to 
manage its corporal cholesterol levels actively through synthesis and excretion of bile acids 
from the liver. Maintaining a stable plasma cholesterol appears to be prioritized over 
stabilising the sterol contents in the liver. 
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5. Future perspectives 
In this experiment we have seen the effect on the cholesterol metabolism of changing the fatty 
acid and sterol composition by varying the dietary lipid sources. To obtain a full overview 
over the sterol metabolism in the salmon, it would be of interest to have a closer look at 
where cholesterol and phytosterols are stored in adult salmon if in excess and which tissues 
are prioritized for receiving cholesterol when feed cholesterol is deficient. To establish some 
guidelines as to how much cholesterol should be present in the feed could also be necessary, 
since plant lipids already are used in a major extent in the aquaculture industry.  
The cholesterol in all the feeds used in this feeding trial were equal to or lower than what a 
fish would get in a marine diet, and the lack of effects on the cholesterol levels in the plasma 
could have been a result of that. In the future, replacing marine lipids with lipids from 
terrestrial animals can become a possibility for the fish feed industry (Bureau and Meeker, 
2011). With prices of fish oil and protein rising, it seems tempting for the aquaculture 
industry to take use of the relatively affordable raw material from terrestrial animal by-
products. These lipid sources might challenge the nutritional status of the fish as they have a 
low content of unsaturated fatty acids as well as a high cholesterol content. In this case, an 
increase in plasma cholesterol and thus a possible increase in risk for aquaculture fish 
developing CVDs, might be a consequence of the diet change.  In a society where the food 
industry produces increasing amounts of animal fats and the supply of marine oils is unstable 
and getting increasingly expensive (Turchini et al., 2009), this might just be a real situation in 
the not-too-distant future. 
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Appendix 
 
 
Figure A.1: Diagnostic plots testing the assumption of homoscedasticity, i.e. constant 
variance along predicted values of the chosen model. Each plot is showing residuals of the 
model chosen versus model predictions. A plot should not show a strong pattern. For 
instance, a fan shaped pattern would mean that the variance increases or decreases along 
increased model predictions. Data used for the example is qPCR results from final sampling. 
 
 
 
 
 
  
 
 
Figure A.2: Normal Q-Q plots testing the assumption of normality, i.e. normal distribution of 
residuals of the chosen model. The plots are comparing quantiles from the model data on the 
vertical axis against theoretical quantiles from a standard normal population on the horizontal 
axis. If data points show strong deviations from the line, the chosen model is assumed to 
violate the assumption of normally distributed residuals. The data used here is the same and 
mentioned in the same order as in A.1. 
 
